{"meta":{"query_hash":"421ddb711e87","filters":{"venue":"Journal of bone oncology"},"cohort_total":54,"direct_labels_cover":0,"predictions_cover":54,"exported":54,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/421ddb711e87","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+bone+oncology"},"results":[{"id":"W1896613973","doi":"10.1016/j.jbo.2015.10.002","title":"Incidence of distal bone metastases in patients treated for palliative radiotherapy and associations with primary tumour types","year":2015,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Northern British Columbia; BC Cancer Agency","funders":"University of British Columbia; University of Northern British Columbia","keywords":"Medicine; Incidence (geometry); Radiation therapy; Palliative care; Internal medicine; Oncology","score_opus":0.028786704035924555,"score_gpt":0.324951998907077,"score_spread":0.29616529487115245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1896613973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982318,0.00068665907,0.000056337893,0.000037851725,0.0000027382982,0.0000062689055,0.00029629562,0.000004215368,0.0006777744],"genre_scores_gemma":[0.99952614,0.00017172899,0.000031058273,0.000009787674,0.0000031036225,0.000002479143,0.00016728217,0.0000012247896,0.00008716872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997348,0.000032411164,0.000026728743,0.000050820294,0.000097278615,0.000057942034],"domain_scores_gemma":[0.99922204,0.000085320404,0.00041445202,0.000021917233,0.00010211223,0.00015416635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015027322,0.00009713179,0.00023711857,0.00066778366,0.00020867288,0.00029659068,0.00022305347,0.0002023842,0.0021351674],"category_scores_gemma":[0.0010594357,0.000098445096,0.0001965781,0.0007286991,0.00022687523,0.000113445996,0.00024121784,0.00029364793,0.00022044047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049912454,0.0000073889423,0.9978671,0.00001565215,0.000016639618,0.00009362004,0.000026026097,0.000034805616,0.00022358951,0.0000046861387,0.00007231768,0.0015881784],"study_design_scores_gemma":[0.000002320133,0.00003472145,0.99861765,0.000006257236,0.000009076535,0.0010094512,0.00006646024,0.000041983643,0.00005566939,0.000004572132,0.00015064573,0.0000012908104],"about_ca_topic_score_codex":0.020232148,"about_ca_topic_score_gemma":0.032918084,"teacher_disagreement_score":0.020232148,"about_ca_system_score_codex":0.0005049743,"about_ca_system_score_gemma":0.0004122167,"threshold_uncertainty_score":0.040228724},"labels":[],"label_agreement":null},{"id":"W1971185937","doi":"10.1016/j.jbo.2013.05.001","title":"A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer","year":2013,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Regional Cancer Foundation; University of Ottawa; Programs for Assessment of Technology in Health Research Institute; Ottawa Hospital","funders":"","keywords":"Medicine; Dosing; Breast cancer; Oncology; Internal medicine; Bone metastasis; Cancer","score_opus":0.03997857791544709,"score_gpt":0.37206425299315693,"score_spread":0.33208567507770986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971185937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022870242,0.9954391,0.00025861218,0.00025786104,0.00014413414,0.00071931945,0.00061766605,0.000012480487,0.00026377675],"genre_scores_gemma":[0.049715366,0.9447584,0.0016119484,0.000943365,0.00013028664,0.0020529185,0.00056908606,0.000014156413,0.00020447785],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.984657,0.0061139665,0.006015222,0.0010566763,0.0019087871,0.00024829336],"domain_scores_gemma":[0.9652995,0.023095336,0.008058696,0.0005784228,0.002621883,0.0003461089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011582209,0.0017337913,0.0131314825,0.008627702,0.0007531544,0.002581426,0.00188707,0.002029113,0.004423417],"category_scores_gemma":[0.045852505,0.0011009747,0.012066931,0.010317104,0.0010770947,0.0021027036,0.0013880889,0.0011435808,0.00031942673],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041631734,0.000012948553,0.0005902555,0.9602625,0.024293566,0.000059405073,0.00008231281,0.00007923921,0.00012289979,0.00008075607,0.00057158596,0.0134283],"study_design_scores_gemma":[0.0011026664,0.0005112411,0.0058149877,0.69021904,0.2894183,0.00035935122,0.00022010086,0.00013815249,0.00024555315,0.00032628502,0.0115934815,0.000050918115],"about_ca_topic_score_codex":0.008728956,"about_ca_topic_score_gemma":0.023024717,"teacher_disagreement_score":0.0131314825,"about_ca_system_score_codex":0.004713946,"about_ca_system_score_gemma":0.010086115,"threshold_uncertainty_score":0.06125331},"labels":[],"label_agreement":null},{"id":"W1978873676","doi":"10.1016/j.jbo.2012.04.003","title":"Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?","year":2012,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Bisphosphonate; Clinical trial; Breast cancer; Oncology; Adjuvant; Internal medicine; Cancer; Osteoporosis","score_opus":0.09803093618672035,"score_gpt":0.4509179672335919,"score_spread":0.3528870310468716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978873676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003554667,0.8394758,0.0005994558,0.15159467,0.0063526784,0.000041382806,0.00011555644,0.0000446655,0.0014202988],"genre_scores_gemma":[0.004860328,0.90851325,0.0030242628,0.06378453,0.01818844,0.000119617616,0.00018885102,0.000052087995,0.0012687114],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930091,0.0033978429,0.0016517777,0.00038548015,0.001290185,0.0002655646],"domain_scores_gemma":[0.9264846,0.039476816,0.0073391804,0.0020842908,0.021819916,0.0027951284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022751838,0.0011247377,0.0038422938,0.004302978,0.0016098982,0.009050956,0.0023769995,0.007636632,0.011275331],"category_scores_gemma":[0.054497786,0.000888242,0.0016774045,0.004376735,0.0043283463,0.017181918,0.0025018656,0.00954444,0.0070654745],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079504313,0.00041510665,0.0024170417,0.02846473,0.00027317807,0.00032457654,0.00041217043,0.0002346855,0.0007711954,0.009440827,0.20764366,0.7488079],"study_design_scores_gemma":[0.00029095222,0.00085200917,0.003764247,0.07983989,0.00065854745,0.00089425885,0.0025469526,0.00032495483,0.00036008214,0.024944432,0.8853342,0.00018939577],"about_ca_topic_score_codex":0.0050546504,"about_ca_topic_score_gemma":0.013203705,"teacher_disagreement_score":0.022751838,"about_ca_system_score_codex":0.0033685956,"about_ca_system_score_gemma":0.010460805,"threshold_uncertainty_score":0.12032467},"labels":[],"label_agreement":null},{"id":"W1984406296","doi":"10.1016/j.jbo.2014.12.001","title":"A definition of “uncomplicated bone metastases” based on previous bone metastases radiation trials comparing single-fraction and multi-fraction radiation therapy","year":2015,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Spinal cord compression; Cauda equina; Pathologic fracture; Radiation therapy; Malignancy; Population; Radiology; Bone pain; Randomized controlled trial; Surgery; Spinal cord; Internal medicine","score_opus":0.21253208445512903,"score_gpt":0.3911379696370026,"score_spread":0.17860588518187356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984406296","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017318673,0.923558,0.0070121074,0.0028812878,0.001799713,0.036783915,0.0037607541,0.00004455845,0.0068409895],"genre_scores_gemma":[0.4131139,0.36050013,0.050501686,0.020833397,0.0020506042,0.14407149,0.0064938366,0.000068198045,0.002366773],"study_design_codex":"systematic_review","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.86734664,0.06610179,0.050579477,0.0037548726,0.011184079,0.0010330924],"domain_scores_gemma":[0.8933687,0.07193035,0.024750425,0.003920035,0.0051200227,0.0009104776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.061420426,0.0017664495,0.00838343,0.008880429,0.0013135169,0.0030489115,0.0028153504,0.004006849,0.004916684],"category_scores_gemma":[0.11104701,0.00086869136,0.015179743,0.009401272,0.0030621514,0.0038375824,0.0029949325,0.0022766385,0.00046986065],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006822482,0.0001932724,0.013657821,0.8452987,0.056470033,0.00046485968,0.0013827852,0.000406297,0.0012794662,0.0066977507,0.006314972,0.06101158],"study_design_scores_gemma":[0.023966353,0.0074902643,0.070867114,0.54752886,0.18497677,0.0028331345,0.0022637642,0.0011285132,0.00225263,0.021859977,0.13444407,0.00038852287],"about_ca_topic_score_codex":0.0028219041,"about_ca_topic_score_gemma":0.009081286,"teacher_disagreement_score":0.061420426,"about_ca_system_score_codex":0.0036240607,"about_ca_system_score_gemma":0.0063140863,"threshold_uncertainty_score":0.32482612},"labels":[],"label_agreement":null},{"id":"W1998536606","doi":"10.1016/j.jbo.2014.10.001","title":"Incidence of pain flare in radiation treatment of bone metastases: A literature review","year":2014,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Incidence (geometry); Flare; Dexamethasone; Radiation therapy; Stereotactic radiation therapy; Surgery; Internal medicine; Radiosurgery","score_opus":0.03583804855435631,"score_gpt":0.3958700356460156,"score_spread":0.3600319870916593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998536606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014227753,0.9978242,0.000042332762,0.00018362123,0.000066221764,0.00004255933,0.00014843732,0.000003926622,0.0002658401],"genre_scores_gemma":[0.012090327,0.9868319,0.00024159989,0.00038307434,0.00014511879,0.0000817705,0.00016136224,0.0000032204794,0.00006159489],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952099,0.00087225577,0.0024053203,0.00041799317,0.0009672492,0.00012732872],"domain_scores_gemma":[0.9739986,0.017380876,0.0059746946,0.00026340125,0.0021622304,0.00022018788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003936813,0.0009840436,0.0037553885,0.017536648,0.0006444898,0.0023156581,0.0017108644,0.0018248813,0.00328249],"category_scores_gemma":[0.017251668,0.0008300715,0.0041017127,0.01857854,0.00082404976,0.0028394016,0.0009926377,0.0008556251,0.0003204415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027618487,0.00005059712,0.0046653054,0.8413074,0.0027000357,0.0007793831,0.0004473131,0.00012188551,0.00033364064,0.0002777711,0.0042946273,0.14474592],"study_design_scores_gemma":[0.00018288042,0.00055397965,0.032668684,0.85662943,0.03835151,0.010993056,0.0015211982,0.00015675416,0.0006440314,0.000567766,0.05762459,0.000106071224],"about_ca_topic_score_codex":0.0034714693,"about_ca_topic_score_gemma":0.006865972,"teacher_disagreement_score":0.017536648,"about_ca_system_score_codex":0.0020549293,"about_ca_system_score_gemma":0.004741407,"threshold_uncertainty_score":0.020820081},"labels":[],"label_agreement":null},{"id":"W2006300879","doi":"10.1016/j.jbo.2013.09.001","title":"Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre","year":2013,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Bone metastasis; Asymptomatic; Bone pain; Incidence (geometry); Cancer; Surgery; Metastatic breast cancer; Oncology; Internal medicine","score_opus":0.02455878055534921,"score_gpt":0.31826234512105267,"score_spread":0.29370356456570346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006300879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516404,0.0028298395,0.00012357076,0.0003650998,0.0000114397835,0.000037749436,0.0004776825,0.000010953376,0.0009796717],"genre_scores_gemma":[0.9974329,0.0018000852,0.00015510942,0.00013630935,0.000026829157,0.000017066275,0.00032482683,0.0000054349043,0.00010148293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775714,0.0007239572,0.0003836677,0.00028289802,0.000597298,0.0002550492],"domain_scores_gemma":[0.9893056,0.00259181,0.005899075,0.00032291154,0.00078581006,0.0010948404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016049196,0.00016484335,0.0006807191,0.00080483634,0.000489362,0.0011400622,0.0005476925,0.00043486402,0.0016855715],"category_scores_gemma":[0.008363732,0.00027868914,0.00046305623,0.0019390178,0.0004962348,0.00049867725,0.00086014223,0.00054045464,0.0002702977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003443877,0.00012937527,0.9796525,0.0002710301,0.00013955319,0.0010535188,0.0008583033,0.00017788018,0.00036726016,0.000048317557,0.00087778206,0.016079972],"study_design_scores_gemma":[0.000055325454,0.0009185897,0.9877439,0.00021287604,0.00011487996,0.0056201634,0.0027361158,0.00020854214,0.000298051,0.00004817626,0.002011331,0.0000319022],"about_ca_topic_score_codex":0.007422412,"about_ca_topic_score_gemma":0.012602595,"teacher_disagreement_score":0.007422412,"about_ca_system_score_codex":0.0013811174,"about_ca_system_score_gemma":0.00162549,"threshold_uncertainty_score":0.014758408},"labels":[],"label_agreement":null},{"id":"W2016849816","doi":"10.1016/j.jbo.2013.01.002","title":"Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials","year":2013,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; McMaster University; University of Waterloo","funders":"Cancer Research UK; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Zoledronic acid; Placebo; Exploratory analysis; Oncology; Internal medicine; Bone metastasis; Overall survival; Cancer; Metastasis; Alternative medicine; Pathology","score_opus":0.03073191591385618,"score_gpt":0.320635401004146,"score_spread":0.28990348509028985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016849816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86311156,0.12086689,0.007326906,0.00071000686,0.00023999886,0.0044008964,0.00182552,0.000102032485,0.0014160454],"genre_scores_gemma":[0.9891747,0.005266461,0.0025691034,0.00024680723,0.00012781424,0.001662485,0.00076908636,0.000010317505,0.00017322927],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96910167,0.026149284,0.0019845134,0.001216244,0.0011255909,0.00042278907],"domain_scores_gemma":[0.9598779,0.03225172,0.0051800143,0.0015272185,0.0007450103,0.00041815924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033352017,0.0014242614,0.00391329,0.0010795951,0.00030809623,0.0014911075,0.0008916266,0.0014198952,0.0019751762],"category_scores_gemma":[0.040825732,0.00047982886,0.011926114,0.0011176586,0.0008853522,0.0010474948,0.0007993474,0.0011156145,0.00015507298],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76942134,0.0010604417,0.03796458,0.0131849935,0.12945072,0.00036978314,0.00019701032,0.0034484137,0.0038628373,0.00070193695,0.0003999026,0.03993799],"study_design_scores_gemma":[0.32020235,0.15918821,0.16503444,0.003050533,0.32286188,0.0010008949,0.00033961562,0.012355794,0.0038695692,0.005699494,0.0062164334,0.00018075483],"about_ca_topic_score_codex":0.00019655787,"about_ca_topic_score_gemma":0.00032484037,"teacher_disagreement_score":0.033352017,"about_ca_system_score_codex":0.0006775429,"about_ca_system_score_gemma":0.0008909816,"threshold_uncertainty_score":0.17638445},"labels":[],"label_agreement":null},{"id":"W2020338108","doi":"10.1016/j.jbo.2012.12.001","title":"Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists","year":2012,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; General surgery; Intensive care medicine","score_opus":0.1826149711384015,"score_gpt":0.45764003461408403,"score_spread":0.27502506347568256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020338108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034793299,0.5578448,0.019841744,0.37747198,0.014941255,0.0007492028,0.001201729,0.0012283034,0.023241669],"genre_scores_gemma":[0.024096176,0.7349522,0.10962308,0.08682028,0.019051485,0.0022195715,0.0014605321,0.00019556712,0.021581016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974566,0.0009982801,0.0006765551,0.00015628718,0.00059874135,0.00011355733],"domain_scores_gemma":[0.9930876,0.0032167244,0.0006654156,0.00021461799,0.0020298695,0.00078578637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042739674,0.0014455038,0.0024003158,0.0040659765,0.0013690914,0.0029463477,0.0020233402,0.0058699474,0.009003926],"category_scores_gemma":[0.011164057,0.0006077231,0.0012730762,0.001652236,0.0012801028,0.0056718276,0.0023244892,0.006448579,0.0061701965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115994146,0.00035669218,0.0033398669,0.0056447503,0.000075512675,0.0021262735,0.0013526249,0.00023273408,0.0008956638,0.0020829414,0.52712226,0.45665473],"study_design_scores_gemma":[0.0001519492,0.0003609845,0.010206983,0.021892032,0.00012950595,0.012328539,0.00784342,0.00044798097,0.0003460821,0.013663312,0.93242645,0.00020276797],"about_ca_topic_score_codex":0.0023247679,"about_ca_topic_score_gemma":0.0054310523,"teacher_disagreement_score":0.009003926,"about_ca_system_score_codex":0.0011379421,"about_ca_system_score_gemma":0.0042084903,"threshold_uncertainty_score":0.030121148},"labels":[],"label_agreement":null},{"id":"W2022705162","doi":"10.1016/j.jbo.2015.01.002","title":"Use of urinary markers in cancer setting: A literature review","year":2015,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Urinary system; Cancer; Oncology; Internal medicine","score_opus":0.1272743023989785,"score_gpt":0.46849810215397636,"score_spread":0.34122379975499784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022705162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022622754,0.9993206,0.00003527348,0.00015630995,0.000050039816,0.000015980633,0.000058750826,0.000002229072,0.0001345229],"genre_scores_gemma":[0.0031135755,0.9962047,0.00017794731,0.0002713639,0.0000870739,0.00003516192,0.00006906788,0.0000016636288,0.000039544924],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969266,0.00074545416,0.0013373028,0.00027886048,0.000609706,0.000102095335],"domain_scores_gemma":[0.97870356,0.016200203,0.0033774911,0.00019250513,0.0013641615,0.00016218568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030000042,0.0011219911,0.0040906155,0.017114282,0.0005827981,0.0020572052,0.0015756396,0.001818137,0.0042872266],"category_scores_gemma":[0.01602814,0.0006196216,0.0032535905,0.020178087,0.00086976844,0.0025794562,0.000961818,0.00095386617,0.00041372786],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000182897,0.00003794453,0.0015680081,0.81039417,0.0015293872,0.0006351148,0.00031609184,0.00014769558,0.0002817828,0.0005449875,0.006391216,0.17797072],"study_design_scores_gemma":[0.000086568885,0.00023242207,0.008611901,0.85687727,0.015457598,0.0051323394,0.0006823956,0.00013347362,0.00043369332,0.000902846,0.111381486,0.00006807569],"about_ca_topic_score_codex":0.0038423322,"about_ca_topic_score_gemma":0.0059712916,"teacher_disagreement_score":0.017114282,"about_ca_system_score_codex":0.0018338277,"about_ca_system_score_gemma":0.0053199637,"threshold_uncertainty_score":0.015865743},"labels":[],"label_agreement":null},{"id":"W2024464990","doi":"10.1016/j.jbo.2012.12.004","title":"Incidence and consequences of bone metastases in lung cancer patients","year":2013,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Lung cancer; Oncology; Internal medicine; Incidence (geometry); Bone pain; Clinical trial; Cancer; Bone metastasis; Surgery; Metastasis","score_opus":0.021951585326602675,"score_gpt":0.36029390040208426,"score_spread":0.33834231507548157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024464990","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42040285,0.5658508,0.0008097495,0.0020522426,0.00014193369,0.00016531527,0.003181962,0.000027893308,0.0073672193],"genre_scores_gemma":[0.94573295,0.0520926,0.00041755912,0.00031324025,0.00016369855,0.000064486485,0.0009519906,0.000005910807,0.0002575401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718374,0.00088867574,0.0005818693,0.00025903308,0.0009885128,0.00009813155],"domain_scores_gemma":[0.98583466,0.0064217667,0.0062004826,0.00020326128,0.0009961523,0.00034374793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030517175,0.00013671097,0.000737404,0.0013050535,0.00021809938,0.000653472,0.0003022403,0.00044493037,0.0022898014],"category_scores_gemma":[0.012809589,0.00011872024,0.0007224494,0.002273349,0.00029198657,0.00044177248,0.00034072448,0.00063268235,0.00015683573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019522287,0.000093146016,0.87425447,0.0075839814,0.0013422656,0.0012685853,0.00018793398,0.00034864346,0.000703883,0.0006228818,0.0016171847,0.11002484],"study_design_scores_gemma":[0.00018444362,0.0014574468,0.96309924,0.0027333659,0.002245382,0.015256109,0.00049184565,0.00037943234,0.0008330823,0.0011210631,0.012159368,0.000039226445],"about_ca_topic_score_codex":0.0007908251,"about_ca_topic_score_gemma":0.0014826094,"teacher_disagreement_score":0.0030517175,"about_ca_system_score_codex":0.0006025485,"about_ca_system_score_gemma":0.00069561024,"threshold_uncertainty_score":0.01613921},"labels":[],"label_agreement":null},{"id":"W2035464928","doi":"10.1016/j.jbo.2012.10.003","title":"Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients–preliminary results","year":2012,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; McGill University; Montreal Children's Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Susan G. Komen","keywords":"Medicine; Trephine; Bone marrow; Biopsy; Metastatic breast cancer; Osteoporosis; Breast cancer; Bisphosphonate; Bone remodeling; Radiology; Bone disease; Cancer; Surgery; Pathology; Internal medicine","score_opus":0.06582766033342885,"score_gpt":0.3901356667220486,"score_spread":0.32430800638861973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035464928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983369,0.0005210197,0.0005226791,0.000034947425,0.0000030387603,0.00007880776,0.00008536711,0.0000135925675,0.00040360575],"genre_scores_gemma":[0.99751914,0.00030409222,0.0016360962,0.000049622522,0.000012181055,0.00004877113,0.00015228518,0.000004025975,0.0002738625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984956,0.00006096925,0.000008625667,0.000025459794,0.00003597436,0.000019394356],"domain_scores_gemma":[0.9998313,0.000042602496,0.000036524878,0.000018359227,0.00003390845,0.000037331436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064617774,0.00046312157,0.00029430067,0.00032079243,0.0001765304,0.00017333742,0.00021811371,0.00029862532,0.0010046728],"category_scores_gemma":[0.0005153799,0.00022483851,0.00019998828,0.00027104243,0.00018437959,0.00011217182,0.00016972345,0.00034306018,0.00023767108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02704395,0.0032321855,0.5398839,0.00033742722,0.00018712244,0.006145452,0.0013328646,0.0013253405,0.3568328,0.00010261318,0.0005945111,0.062981874],"study_design_scores_gemma":[0.00062217296,0.013547582,0.9535839,0.000015355168,0.00013690496,0.0071233264,0.0003185735,0.0018209195,0.021707144,0.00010258157,0.0010022615,0.00001930821],"about_ca_topic_score_codex":0.0013204128,"about_ca_topic_score_gemma":0.0018625215,"teacher_disagreement_score":0.0013204128,"about_ca_system_score_codex":0.00019342902,"about_ca_system_score_gemma":0.00019375038,"threshold_uncertainty_score":0.003417313},"labels":[],"label_agreement":null},{"id":"W2035658132","doi":"10.1016/j.jbo.2012.09.001","title":"A national portfolio of bone oncology trials—The Canadian experience in 2012","year":2012,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Clinical trial; Breast cancer; Oncology; Cancer; Internal medicine; Bone metastasis","score_opus":0.2824228390646103,"score_gpt":0.5090113110251142,"score_spread":0.2265884719605039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035658132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005783567,0.9732738,0.00035504712,0.0063814116,0.0004196304,0.0007003611,0.0019974879,0.000040759627,0.011048015],"genre_scores_gemma":[0.062190726,0.9185528,0.005175085,0.0057993443,0.0003173879,0.0006154606,0.002460467,0.00005523689,0.0048334966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99251056,0.0017333038,0.0010551035,0.00043948146,0.0036642388,0.00059724145],"domain_scores_gemma":[0.9775654,0.004223686,0.0023540347,0.0006036702,0.012640673,0.0026126257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015997397,0.00091486424,0.0022540777,0.003644797,0.0015371859,0.0041324627,0.0019741904,0.0013927632,0.003948571],"category_scores_gemma":[0.028964613,0.0004312515,0.0010507476,0.011412915,0.00093224377,0.0009739621,0.0012480244,0.0013683497,0.0005855182],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017120912,0.00017670427,0.0039816173,0.032185044,0.0008510715,0.00043638324,0.0007810892,0.00054299185,0.0013098072,0.004180724,0.11381916,0.8400233],"study_design_scores_gemma":[0.0013386243,0.0006692243,0.03100012,0.039619155,0.0032677208,0.0011477213,0.0006349179,0.00023617556,0.0012973228,0.001057876,0.9196341,0.00009704464],"about_ca_topic_score_codex":0.6381097,"about_ca_topic_score_gemma":0.82237184,"teacher_disagreement_score":0.96212244,"about_ca_system_score_codex":0.037877534,"about_ca_system_score_gemma":0.14908612,"threshold_uncertainty_score":0.7280431},"labels":[],"label_agreement":null},{"id":"W2036268292","doi":"10.1016/j.jbo.2014.01.001","title":"Bone-targeted therapy for metastatic breast cancer—Where do we go from here? A commentary from the BONUS 8 meeting","year":2014,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"Amgen","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Bone metastasis; Cancer; Oncology; Metastasis; Internal medicine","score_opus":0.027885911668575982,"score_gpt":0.34421902200268256,"score_spread":0.3163331103341066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036268292","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004989311,0.008629113,0.000047627636,0.94195515,0.048957113,0.0000059275108,0.00002304069,0.000010021565,0.0003220902],"genre_scores_gemma":[0.0009967689,0.0054207966,0.00012695484,0.94268405,0.049477436,0.000025268328,0.0000149498865,0.00002226435,0.0012314377],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98947257,0.0041375784,0.0013339545,0.0011271741,0.0030103875,0.0009183283],"domain_scores_gemma":[0.9428839,0.037556235,0.002288836,0.00058423367,0.013317751,0.0033690843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016133545,0.0014018227,0.0023966567,0.0014121279,0.005435309,0.0041880505,0.0051190737,0.04719435,0.0064188354],"category_scores_gemma":[0.07313818,0.00086838426,0.0027185346,0.0015185196,0.00601859,0.009162888,0.0027283875,0.07513838,0.003611182],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066662295,0.000009513697,0.000054557513,0.00020233645,0.000014650328,0.00012480219,0.00014212461,0.00003152552,0.00006966442,0.0011005676,0.99228466,0.005898978],"study_design_scores_gemma":[0.00008888672,0.000064436106,0.00043944057,0.0015775777,0.000069368914,0.00037587289,0.00059485773,0.00012496102,0.00018122983,0.003159597,0.99324244,0.00008131546],"about_ca_topic_score_codex":0.017046124,"about_ca_topic_score_gemma":0.03411025,"teacher_disagreement_score":0.04719435,"about_ca_system_score_codex":0.007256125,"about_ca_system_score_gemma":0.011711544,"threshold_uncertainty_score":0.08532339},"labels":[],"label_agreement":null},{"id":"W2036341672","doi":"10.1016/j.jbo.2012.10.001","title":"Skeletal morbidity rates over time in patients with bone metastases from solid tumors reported in bone modifying agents randomised trials","year":2012,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Placebo; Confounding; Incidence (geometry); Clinical trial; Malignancy; Internal medicine; Surgery; Pathology; Alternative medicine","score_opus":0.0662738619205359,"score_gpt":0.3825583529796437,"score_spread":0.3162844910591078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036341672","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10121045,0.8805526,0.0038002084,0.0008898567,0.0007534677,0.003403614,0.0063210353,0.00009014917,0.0029786304],"genre_scores_gemma":[0.7272553,0.2465519,0.0048716906,0.0015130517,0.00068829564,0.010712712,0.006906345,0.00008434818,0.0014164562],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9159781,0.040095717,0.029033877,0.005234737,0.008767442,0.0008901535],"domain_scores_gemma":[0.8813312,0.06893885,0.04268815,0.002411256,0.0040209224,0.0006095648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06069215,0.0010675723,0.006545851,0.0050142654,0.00046447245,0.0026829755,0.0011072841,0.0016548014,0.0029808441],"category_scores_gemma":[0.11539306,0.0008315702,0.01696152,0.0073815384,0.00095160544,0.0018249647,0.0013921334,0.0020270853,0.00035209104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12289911,0.0003116986,0.13048589,0.30725497,0.3296886,0.0004471112,0.0007427134,0.0020412304,0.0020343394,0.0011217709,0.003742226,0.099230394],"study_design_scores_gemma":[0.05006142,0.023837326,0.38002437,0.077289455,0.42825055,0.002477706,0.0008187463,0.0017932454,0.0035065953,0.002793893,0.028798742,0.00034780393],"about_ca_topic_score_codex":0.0010606433,"about_ca_topic_score_gemma":0.0019318333,"teacher_disagreement_score":0.06069215,"about_ca_system_score_codex":0.0016853822,"about_ca_system_score_gemma":0.0017713179,"threshold_uncertainty_score":0.3209746},"labels":[],"label_agreement":null},{"id":"W2038602339","doi":"10.1016/j.jbo.2014.11.001","title":"Quality of life after palliative radiotherapy in bone metastases: A literature review","year":2014,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Quality of life (healthcare); Radiation therapy; Palliative care; MEDLINE; Physical therapy; Prospective cohort study; Surgery; Nursing","score_opus":0.0662088627487887,"score_gpt":0.4469231443958604,"score_spread":0.38071428164707166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038602339","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028011086,0.999479,0.000015049001,0.000065827946,0.000030127623,0.000020327072,0.000025372763,0.0000011536746,0.0000830937],"genre_scores_gemma":[0.0027210105,0.99694794,0.00008891908,0.00009636825,0.00003428456,0.000046238387,0.00002946098,7.061621e-7,0.000035119494],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982905,0.0005304585,0.00060252624,0.00013944264,0.00036179615,0.00007534657],"domain_scores_gemma":[0.9939393,0.0042806617,0.0011868024,0.000050883027,0.00045318087,0.000089182155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028234115,0.0010908772,0.0045723165,0.00686057,0.00049291336,0.0016176932,0.001391342,0.0014756086,0.0037695728],"category_scores_gemma":[0.009731296,0.00055696466,0.0028575817,0.008726307,0.0005767132,0.0015649266,0.0008651385,0.00086836645,0.000275102],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018842402,0.00004192141,0.00061491714,0.8279009,0.002084898,0.00019379679,0.00019632895,0.00011523261,0.00017259161,0.00022321066,0.0032300313,0.16503769],"study_design_scores_gemma":[0.00027030637,0.0005577962,0.010381758,0.88987255,0.027927838,0.002446834,0.0007283944,0.00012704259,0.00030505858,0.0004677085,0.06685513,0.00005945968],"about_ca_topic_score_codex":0.0038888964,"about_ca_topic_score_gemma":0.008763591,"teacher_disagreement_score":0.00686057,"about_ca_system_score_codex":0.002043172,"about_ca_system_score_gemma":0.0042010904,"threshold_uncertainty_score":0.014931798},"labels":[],"label_agreement":null},{"id":"W2039202969","doi":"10.1016/j.jbo.2013.07.004","title":"Effects of de-escalated bisphosphonate therapy on the Functional Assessment of Cancer Therapy-Bone Pain, Brief Pain Inventory and bone biomarkers","year":2013,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"","keywords":"Medicine; Brief Pain Inventory; N-terminal telopeptide; Randomized controlled trial; Bone remodeling; Internal medicine; Bone metastasis; Physical therapy; Cancer; Oncology; Chronic pain; Alkaline phosphatase; Breast cancer; Osteocalcin","score_opus":0.01997138998426317,"score_gpt":0.32127387664546164,"score_spread":0.30130248666119847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039202969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941158,0.0038569602,0.00021861191,0.00026198753,0.00009690637,0.0006652701,0.00016849207,0.000024022154,0.0005919241],"genre_scores_gemma":[0.99510694,0.0016606669,0.0012318798,0.00032918027,0.00011451336,0.0007562057,0.00029616972,0.0000056149825,0.0004989756],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99874485,0.00076603255,0.000119781485,0.00011566365,0.00012816615,0.00012551052],"domain_scores_gemma":[0.9980509,0.00091989513,0.00047456528,0.00015284373,0.0000893431,0.00031242837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021883317,0.00064942084,0.001967561,0.00042697336,0.00017911915,0.00041310614,0.00061718153,0.0006656354,0.0025087963],"category_scores_gemma":[0.00336216,0.00026580063,0.00095690315,0.00035451594,0.00039859116,0.0004118593,0.0004516403,0.0016477823,0.00022500685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8576034,0.022316296,0.003701726,0.0010485926,0.0015190134,0.000047900437,0.000090151596,0.0015849562,0.006824455,0.00013159757,0.00040140792,0.10473065],"study_design_scores_gemma":[0.49124023,0.4720655,0.030167198,0.00014062198,0.0015183612,0.00011399997,0.00003488813,0.0016622538,0.0017760829,0.00026546087,0.0009949981,0.00002040962],"about_ca_topic_score_codex":0.000578851,"about_ca_topic_score_gemma":0.0013858106,"teacher_disagreement_score":0.0025087963,"about_ca_system_score_codex":0.00044470816,"about_ca_system_score_gemma":0.0006688824,"threshold_uncertainty_score":0.011573136},"labels":[],"label_agreement":null},{"id":"W2042981948","doi":"10.1016/j.jbo.2013.06.001","title":"Does estrogen play a role in response to adjuvant bone-targeted therapies?","year":2013,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Alberta; University of Toronto; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; Estrogen; Breast cancer; Clinical trial; Oncology; Adjuvant therapy; Randomized controlled trial; Population; Disease; Internal medicine; Bioinformatics; Cancer","score_opus":0.035666297597956705,"score_gpt":0.3896553244175404,"score_spread":0.3539890268195837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042981948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010407554,0.9995485,0.000009251211,0.00017779917,0.00004019072,0.0000012761443,0.0000063717343,4.2887865e-7,0.000112023125],"genre_scores_gemma":[0.0015914346,0.9980332,0.000026580972,0.00015228959,0.00010683219,0.0000033641688,0.0000087509325,4.165506e-7,0.00007709053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994429,0.00019915965,0.000127103,0.00006671586,0.00013507676,0.000029052893],"domain_scores_gemma":[0.9984028,0.0012144813,0.00021126811,0.000019724464,0.0001308082,0.000020989817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014103,0.00043203615,0.0025443342,0.001167747,0.0001263662,0.0009283004,0.00083148543,0.0011522943,0.0027658697],"category_scores_gemma":[0.0033984482,0.00025817816,0.0008830968,0.0014141122,0.00060959737,0.0008626295,0.0003535151,0.0010876941,0.0006267695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051031285,0.00006939886,0.0013463384,0.064408235,0.0007569756,0.00020755538,0.00008559488,0.00026779657,0.000602328,0.002204008,0.009757485,0.91978395],"study_design_scores_gemma":[0.00062627194,0.0013643001,0.024212359,0.11052185,0.0059836847,0.0065134615,0.00063070486,0.00042274405,0.001478381,0.006743317,0.84140766,0.00009521529],"about_ca_topic_score_codex":0.0014933087,"about_ca_topic_score_gemma":0.0026262826,"teacher_disagreement_score":0.0027658697,"about_ca_system_score_codex":0.00061767735,"about_ca_system_score_gemma":0.0011729688,"threshold_uncertainty_score":0.009252727},"labels":[],"label_agreement":null},{"id":"W2045714222","doi":"10.1016/j.jbo.2013.04.003","title":"The failures and challenges of bone metastases research in radiation oncology","year":2013,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Intensive care medicine; High-intensity focused ultrasound; Radiation therapy; Clinical trial; Stereotactic radiation therapy; Population; Narrative review; Radiation oncology; Medical physics; Cancer; Surgery; Radiology; Internal medicine; Radiosurgery; Ultrasound","score_opus":0.10558873421940422,"score_gpt":0.4155344407696899,"score_spread":0.30994570655028564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045714222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010086226,0.8844409,0.004301369,0.10147293,0.0060629016,0.000052546602,0.000045666082,0.00003898859,0.0025762073],"genre_scores_gemma":[0.014123121,0.9181804,0.016571704,0.03435175,0.015223666,0.00015284517,0.000090706606,0.00009395706,0.0012119558],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9158605,0.04871802,0.010239576,0.0039370605,0.020065183,0.001179725],"domain_scores_gemma":[0.6006749,0.3310012,0.014057178,0.010357427,0.039677918,0.0042313607],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14938833,0.0010368708,0.0038973873,0.0057284944,0.002390514,0.011386792,0.003612481,0.0074385754,0.0036410636],"category_scores_gemma":[0.1674865,0.0011697147,0.0024344064,0.0054379986,0.010293206,0.018238883,0.0066529666,0.01442873,0.0023882985],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022625591,0.00013405897,0.0030266761,0.024355898,0.00040319865,0.0005115735,0.002390223,0.0008125658,0.0010811033,0.051240433,0.06280007,0.8530179],"study_design_scores_gemma":[0.00008664734,0.0009397613,0.0037610536,0.059148658,0.0005463675,0.004059198,0.0055159093,0.00073729025,0.0011814944,0.13152902,0.79225296,0.00024161965],"about_ca_topic_score_codex":0.002685748,"about_ca_topic_score_gemma":0.005911369,"teacher_disagreement_score":0.8506117,"about_ca_system_score_codex":0.006265575,"about_ca_system_score_gemma":0.014721965,"threshold_uncertainty_score":0.79005045},"labels":[],"label_agreement":null},{"id":"W2063960427","doi":"10.1016/j.jbo.2013.03.001","title":"De-escalated administration of bone-targeted agents in patients with breast and prostate cancer—A survey of Canadian oncologists","year":2013,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Alberta; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Prostate cancer; Breast cancer; Oncology; Clinical endpoint; Clinical trial; Disease; Internal medicine; Cancer","score_opus":0.02559960462374893,"score_gpt":0.3174538661922139,"score_spread":0.29185426156846495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063960427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810431,0.0032303745,0.00011823043,0.008080699,0.000040392217,0.00009932567,0.0018212973,0.000013201947,0.0055535203],"genre_scores_gemma":[0.9950512,0.002083314,0.000274464,0.0016717874,0.000025716234,0.000026097649,0.00046997302,0.0000033275135,0.0003940708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644655,0.00055286667,0.00033413668,0.00027856542,0.0018209323,0.0005669391],"domain_scores_gemma":[0.9864027,0.0017680771,0.005240843,0.00017610706,0.003826232,0.0025861869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00244303,0.0001424267,0.00023022383,0.0010218633,0.0016880215,0.0007866747,0.00083981355,0.0006419769,0.0016045207],"category_scores_gemma":[0.011185814,0.00026691804,0.00033437996,0.0031735091,0.00065355795,0.0004176003,0.0005930569,0.0007419459,0.00017883227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010374289,0.000060432812,0.97979033,0.00019553567,0.00003835179,0.00013844176,0.0028592,0.00009428923,0.00029702505,0.00007834009,0.0040515084,0.012292827],"study_design_scores_gemma":[0.000014298309,0.000077628145,0.9920161,0.00009502368,0.000016322081,0.00016619811,0.003324872,0.00015722602,0.000049922284,0.0000101846945,0.004058487,0.000013696667],"about_ca_topic_score_codex":0.9118883,"about_ca_topic_score_gemma":0.9333316,"teacher_disagreement_score":0.0881117,"about_ca_system_score_codex":0.0134654315,"about_ca_system_score_gemma":0.019575803,"threshold_uncertainty_score":0.17726117},"labels":[],"label_agreement":null},{"id":"W2067859228","doi":"10.1016/j.jbo.2013.05.002","title":"Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey","year":2013,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Prostate cancer; Denosumab; Cancer; Oncology; Clinical trial; Internal medicine; Prostate; Metastatic breast cancer; Osteoporosis","score_opus":0.0421504713115701,"score_gpt":0.34346235779065215,"score_spread":0.301311886479082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067859228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525285,0.00016147629,0.00009580895,0.0005360296,0.000005255024,0.00010425663,0.0021194194,0.000007974137,0.0017169656],"genre_scores_gemma":[0.9979336,0.00023808719,0.00021405942,0.00035319786,0.000007042493,0.00006077227,0.0009016085,0.0000018063571,0.0002899299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989262,0.0002444991,0.000142078,0.000084532476,0.00033981024,0.00026275186],"domain_scores_gemma":[0.99724627,0.00046412312,0.0009230194,0.000050886083,0.0006893389,0.0006264234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012358645,0.00012955755,0.00021806505,0.0006622826,0.00067025184,0.0004769633,0.00025821288,0.00041721412,0.0020535383],"category_scores_gemma":[0.0027220233,0.0001658834,0.00028242424,0.0015184206,0.00037013934,0.0003924892,0.00047449276,0.0005735385,0.00035672486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042340536,0.000044834367,0.99477947,0.000052234092,0.000013937363,0.0000638372,0.0009358969,0.000051469513,0.00018680345,0.00001150263,0.0008678311,0.0029499223],"study_design_scores_gemma":[0.0000035359024,0.00012341836,0.99693465,0.000013189959,0.0000048880315,0.00013408173,0.0016772543,0.00007282225,0.000039990693,0.0000044546964,0.0009862192,0.0000056503936],"about_ca_topic_score_codex":0.16925459,"about_ca_topic_score_gemma":0.19918302,"teacher_disagreement_score":0.16925459,"about_ca_system_score_codex":0.002015723,"about_ca_system_score_gemma":0.0021521705,"threshold_uncertainty_score":0.33653885},"labels":[],"label_agreement":null},{"id":"W2068518767","doi":"10.1016/j.jbo.2014.10.003","title":"International patterns of practice in radiotherapy for bone metastases: A review of the literature","year":2014,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Response Biomedical (Canada)","funders":"Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Radiation therapy; MEDLINE; Dose fractionation; Randomized controlled trial; Systematic review; Medical prescription; Surgery","score_opus":0.031971386195718474,"score_gpt":0.42728045317164726,"score_spread":0.39530906697592877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068518767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012528086,0.99670583,0.00011256133,0.0010759941,0.00013893968,0.000046970534,0.00013575559,0.0000053238678,0.0005258161],"genre_scores_gemma":[0.01372265,0.98421556,0.0006857671,0.00094717846,0.00011162389,0.0001035006,0.00014484189,0.000005719938,0.00006318814],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9860357,0.0036512748,0.0060337684,0.0011475481,0.0028639173,0.00026776193],"domain_scores_gemma":[0.8948048,0.071622685,0.022638017,0.001097494,0.00910163,0.00073528284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016819086,0.0009701507,0.0029997576,0.020930208,0.00073313643,0.0038082912,0.0022054017,0.002098138,0.0027246976],"category_scores_gemma":[0.06844042,0.00081964734,0.0027727715,0.03736478,0.0018382724,0.0038457538,0.0016302919,0.0011003955,0.00040677353],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022282607,0.000052456646,0.011125025,0.60168415,0.0031330525,0.00039176567,0.0022426583,0.0002880869,0.00019512493,0.0017025373,0.010466277,0.36849606],"study_design_scores_gemma":[0.00009694439,0.00017129607,0.032271147,0.8839964,0.012065392,0.0017873972,0.0034688564,0.00020474335,0.0001954862,0.0014954571,0.06416571,0.0000811784],"about_ca_topic_score_codex":0.011165758,"about_ca_topic_score_gemma":0.024979088,"teacher_disagreement_score":0.020930208,"about_ca_system_score_codex":0.0053402414,"about_ca_system_score_gemma":0.013357781,"threshold_uncertainty_score":0.088948905},"labels":[],"label_agreement":null},{"id":"W2075167228","doi":"10.1016/j.jbo.2012.04.002","title":"A review of recently published radiotherapy treatment guidelines for bone metastases: Contrasts or convergence?","year":2012,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiation therapy; Reimbursement; External beam radiotherapy; Medical physics; Psychological intervention; Cancer; Radiology; Intensive care medicine; Health care; Brachytherapy; Internal medicine; Nursing","score_opus":0.26147331249897926,"score_gpt":0.49675038554221723,"score_spread":0.23527707304323797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075167228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009456788,0.99781346,0.00012573943,0.0008232188,0.00035425753,0.000015385898,0.000061040955,0.000006855885,0.0007055163],"genre_scores_gemma":[0.0005978551,0.997592,0.00052707014,0.00078258355,0.00014597179,0.000019866015,0.000116417934,0.0000033093354,0.00021500482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982486,0.0004397352,0.00055011135,0.00014027437,0.00056168373,0.00005967132],"domain_scores_gemma":[0.99295336,0.003940571,0.0012359064,0.000102628386,0.0016259368,0.00014167812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031194624,0.0008298656,0.001974322,0.0068863337,0.00036772992,0.0011833851,0.0016262679,0.0014102007,0.0037164628],"category_scores_gemma":[0.011973333,0.00050390227,0.0012254221,0.011994702,0.0005819946,0.0017408943,0.00068987213,0.001470747,0.0011144483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049081504,0.00003953469,0.00032904302,0.10399681,0.00029058693,0.00016312813,0.00022593819,0.00030332746,0.000290393,0.0028292148,0.093549035,0.7979339],"study_design_scores_gemma":[0.00003182698,0.00006638559,0.0021134967,0.09844568,0.0009345326,0.0012636468,0.00024031335,0.00009115362,0.00020230238,0.0012020912,0.8953706,0.000038060534],"about_ca_topic_score_codex":0.004527028,"about_ca_topic_score_gemma":0.010150184,"teacher_disagreement_score":0.0068863337,"about_ca_system_score_codex":0.0016694504,"about_ca_system_score_gemma":0.005839219,"threshold_uncertainty_score":0.016497552},"labels":[],"label_agreement":null},{"id":"W2082459525","doi":"10.1016/j.jbo.2012.12.003","title":"‘Who’, ‘when’ and ‘how’ in re-irradiation of recurrent painful bone metastases","year":2013,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Radiation therapy; Irradiation; Pain relief; Randomized controlled trial; Clinical trial; Surgery; Bone metastasis; Metastasis; Cancer; Internal medicine","score_opus":0.0884661989795419,"score_gpt":0.3910398299094862,"score_spread":0.3025736309299443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082459525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011169748,0.99933535,0.000025898651,0.00023535373,0.00006367384,0.000004448214,0.000007309601,8.827036e-7,0.00021544321],"genre_scores_gemma":[0.0012145003,0.99829656,0.00010049734,0.0001952075,0.000072430405,0.000006388051,0.000010756643,6.17495e-7,0.00010299699],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995498,0.00018428538,0.00009535495,0.000055868422,0.00008960879,0.000025096211],"domain_scores_gemma":[0.999371,0.00044221635,0.00010669387,0.00000865642,0.000054813147,0.000016666952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010845279,0.0005855028,0.0018336863,0.0011286411,0.00021738872,0.0008695749,0.00082478195,0.0012115597,0.002783116],"category_scores_gemma":[0.0022333271,0.0002330445,0.0014215377,0.0013222282,0.00043916714,0.0012648158,0.000366686,0.0012015909,0.00044275375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031780658,0.000078288256,0.00040827744,0.148945,0.0008558695,0.00017428612,0.0001477623,0.00024375152,0.00065187074,0.0016631512,0.016171575,0.8303423],"study_design_scores_gemma":[0.0005619962,0.000644266,0.008328021,0.22652994,0.005555817,0.005635932,0.00048338182,0.0003262644,0.0011933447,0.0040603024,0.7466028,0.00007790391],"about_ca_topic_score_codex":0.0012730331,"about_ca_topic_score_gemma":0.003358198,"teacher_disagreement_score":0.002783116,"about_ca_system_score_codex":0.0005606589,"about_ca_system_score_gemma":0.00095980446,"threshold_uncertainty_score":0.009310484},"labels":[],"label_agreement":null},{"id":"W2274459853","doi":"10.1016/j.jbo.2016.02.004","title":"Future directions for bone metastasis research – highlights from the 2015 bone and the Oncologist new updates conference (BONUS)","year":2016,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University Health Network; McMaster University; Sunnybrook Health Science Centre; McGill University Health Centre; University of Ottawa; McGill University; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"Amgen Canada; Amgen","keywords":"Medicine; Bone metastasis; Oncology; Alternative medicine; Clinical Practice; Basic research; Medical education; Metastasis; Internal medicine; Cancer; Family medicine; Pathology; Library science","score_opus":0.17369907100323834,"score_gpt":0.48065221188329776,"score_spread":0.3069531408800594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274459853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000120244615,0.96420914,0.00011453442,0.020297468,0.013986663,0.000017377497,0.000030042036,0.000011463851,0.0012130998],"genre_scores_gemma":[0.0010913133,0.9752993,0.00041515147,0.009301782,0.011868196,0.00003275956,0.00009192422,0.000009654558,0.0018898798],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820507,0.00052023743,0.00021465372,0.00014671276,0.0007080125,0.00020532584],"domain_scores_gemma":[0.9931764,0.0030639062,0.0005112311,0.00010768248,0.0022974564,0.00084328366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066161477,0.0009596669,0.0012103162,0.002657924,0.00061403227,0.0029374731,0.0011185431,0.0029049804,0.008107105],"category_scores_gemma":[0.007661356,0.0003803346,0.0014074154,0.0023869334,0.000819638,0.00496842,0.001538426,0.0046154195,0.0027820983],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019801145,0.000080214326,0.00015918148,0.020855889,0.00008651428,0.000396806,0.0002934927,0.00018027729,0.0010539811,0.0072835446,0.50257784,0.46683422],"study_design_scores_gemma":[0.00002168905,0.00007995976,0.0004262628,0.0058333804,0.000053151834,0.00044178957,0.00019741994,0.000031463984,0.0001257458,0.0020826373,0.99068695,0.000019605133],"about_ca_topic_score_codex":0.0015480239,"about_ca_topic_score_gemma":0.0044379663,"teacher_disagreement_score":0.008107105,"about_ca_system_score_codex":0.0018504823,"about_ca_system_score_gemma":0.0049232394,"threshold_uncertainty_score":0.034989953},"labels":[],"label_agreement":null},{"id":"W2279538354","doi":"10.1016/j.jbo.2016.01.001","title":"A comparative study between limb-salvage and amputation for treating osteosarcoma","year":2016,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Yunnan Provincial Science and Technology Department; China Postdoctoral Science Foundation","keywords":"Medicine; Amputation; Osteosarcoma; Confidence interval; Odds ratio; Surgery; Salvage therapy; Meta-analysis; MEDLINE; Internal medicine; Chemotherapy; Pathology","score_opus":0.13492913674590012,"score_gpt":0.46584394582752603,"score_spread":0.3309148090816259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279538354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005415156,0.9938937,0.0001522682,0.00008840883,0.00009305661,0.00011542766,0.000062998224,0.000003979674,0.00017495702],"genre_scores_gemma":[0.14408527,0.8531389,0.0011334899,0.00052264176,0.00029618383,0.00039667144,0.00021715467,0.000009316874,0.00020036826],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994426,0.0026269548,0.0016880686,0.0005023615,0.00063111784,0.00012539339],"domain_scores_gemma":[0.9853351,0.011412103,0.0020915724,0.00021338453,0.0007750969,0.00017269005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007581262,0.00143768,0.00965478,0.0046775136,0.00047533074,0.0020408605,0.0012753493,0.0015997536,0.003123969],"category_scores_gemma":[0.020246847,0.0006738122,0.016078763,0.004753361,0.0005093121,0.0013827084,0.00069342833,0.0010352826,0.00017060465],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062083774,0.00017181397,0.005857635,0.55385303,0.384995,0.00028331764,0.00014699403,0.00028737308,0.00069416536,0.00022086568,0.000395558,0.046885815],"study_design_scores_gemma":[0.0017410335,0.0017480152,0.008026692,0.049725138,0.93420625,0.00044418988,0.00016679439,0.00017689947,0.00032161654,0.00029766717,0.003112009,0.00003369132],"about_ca_topic_score_codex":0.0020559232,"about_ca_topic_score_gemma":0.005446118,"teacher_disagreement_score":0.00965478,"about_ca_system_score_codex":0.0013587556,"about_ca_system_score_gemma":0.0021064428,"threshold_uncertainty_score":0.040094018},"labels":[],"label_agreement":null},{"id":"W2466757454","doi":"10.1016/j.jbo.2016.07.001","title":"Strategies for obtaining bone biopsy specimens from breast cancer patients – Past experience and future directions","year":2016,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Electricity Association; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Breast cancer; Iliac crest; Cancer; Biopsy; Radiology; Bisphosphonate; Pathology; Surgery; Internal medicine; Osteoporosis","score_opus":0.02057794927004707,"score_gpt":0.3363570598009522,"score_spread":0.3157791105309051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466757454","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045519408,0.8148237,0.049446397,0.06158667,0.0017212816,0.0006309446,0.0002797263,0.000516712,0.025475139],"genre_scores_gemma":[0.17168777,0.61166483,0.19209257,0.013918239,0.0031637684,0.0006679059,0.0009803374,0.0002219656,0.005602563],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9931873,0.0034389042,0.00067117857,0.0006953794,0.0016334101,0.0003738585],"domain_scores_gemma":[0.9848092,0.0054757106,0.0017613472,0.0016610224,0.004776088,0.0015165637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022208113,0.0010463399,0.00051769195,0.004316805,0.0011445011,0.0026955954,0.0037165175,0.001977457,0.0042293156],"category_scores_gemma":[0.020029664,0.0005330543,0.0008854222,0.0018868068,0.0035295244,0.0030668322,0.0023825523,0.0028321042,0.002888654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029480545,0.0006530572,0.039337926,0.0045359214,0.000093214694,0.002837633,0.0024041077,0.00085572683,0.0050116493,0.0031115129,0.0169446,0.9239199],"study_design_scores_gemma":[0.0001803327,0.0023155874,0.08871865,0.018587442,0.00041920753,0.08166311,0.020790616,0.002051266,0.014837773,0.015532311,0.75452405,0.00037960705],"about_ca_topic_score_codex":0.00516168,"about_ca_topic_score_gemma":0.011579867,"teacher_disagreement_score":0.022208113,"about_ca_system_score_codex":0.0019261607,"about_ca_system_score_gemma":0.0038673037,"threshold_uncertainty_score":0.117449105},"labels":[],"label_agreement":null},{"id":"W2467063095","doi":"10.1016/j.jbo.2016.06.003","title":"A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer","year":2016,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society","keywords":"Medicine; Breast cancer; Denosumab; Bone remodeling; Internal medicine; Bone pain; Metastatic breast cancer; Oncology; Clinical endpoint; Bone resorption; Osteonecrosis of the jaw; Population; Adverse effect; Bone metastasis; Cancer; Osteoporosis; Clinical trial; Bisphosphonate","score_opus":0.054632756944762086,"score_gpt":0.3923877361309718,"score_spread":0.33775497918620967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467063095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906018,0.0014372601,0.00032612955,0.00041793397,0.00012127872,0.005033171,0.00081416545,0.00004929646,0.0011991081],"genre_scores_gemma":[0.98380536,0.0013886287,0.0016101447,0.0008006342,0.00031291303,0.007459131,0.0019346738,0.000018700819,0.0026698487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994497,0.00026510685,0.000027537124,0.000103626226,0.000042761072,0.000111317306],"domain_scores_gemma":[0.99901116,0.00021716398,0.00019478338,0.000080441234,0.00006422925,0.00043218827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018714863,0.0015685591,0.0021146336,0.000515516,0.000387137,0.00083856727,0.0007817817,0.0016779173,0.0055367453],"category_scores_gemma":[0.0013294043,0.00055108836,0.001002852,0.00045829298,0.000918565,0.0007670051,0.00048992084,0.0026127705,0.0009066283],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.874106,0.06531048,0.0029190902,0.00062854163,0.00049084006,0.00017445018,0.00015316227,0.0008698634,0.0148948645,0.00011478842,0.0012327803,0.03910527],"study_design_scores_gemma":[0.6034805,0.39014757,0.003973026,0.000018856064,0.00012076141,0.00009742796,0.000020751722,0.0003231441,0.0009977055,0.00006782861,0.00074126996,0.000011152986],"about_ca_topic_score_codex":0.0005580088,"about_ca_topic_score_gemma":0.0013784722,"teacher_disagreement_score":0.0055367453,"about_ca_system_score_codex":0.0007290474,"about_ca_system_score_gemma":0.0015303035,"threshold_uncertainty_score":0.018522203},"labels":[],"label_agreement":null},{"id":"W2575801585","doi":"10.1016/j.jbo.2017.01.001","title":"Intra-tumor delivery of zoledronate mitigates metastasis-induced osteolysis superior to systemic administration","year":2017,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Cancer Society Research Institute; Natural Sciences and Engineering Research Council of Canada; Mitacs","keywords":"Medicine; Systemic administration; Osteolysis; Lesion; Bone metastasis; Bisphosphonate; Metastasis; Internal medicine; Oncology; Urology; Surgery; Cancer; In vivo; Osteoporosis","score_opus":0.03558742255235599,"score_gpt":0.35320702271244625,"score_spread":0.3176196001600903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575801585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787644,0.004138304,0.0069168555,0.0006398891,0.00042788024,0.00018580572,0.0009531083,0.00080790767,0.007165865],"genre_scores_gemma":[0.98555726,0.0015618374,0.0034032313,0.00011758812,0.00006111782,0.000098359735,0.00057386135,0.00005175839,0.008575032],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998061,0.000025937135,0.000008226182,0.000028462551,0.000047604342,0.00008376763],"domain_scores_gemma":[0.9998878,0.000030820935,0.000015521331,0.000013164243,0.000013016037,0.000039645198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002010404,0.00044367946,0.0005558639,0.0004522027,0.0001904086,0.00042657816,0.00027478876,0.0004077441,0.005713861],"category_scores_gemma":[0.00022954983,0.00015677891,0.00026930656,0.00029661471,0.00057927094,0.00040431108,0.00018481523,0.0012668263,0.00068852503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042100833,0.0009866955,0.00027335214,0.00028914365,0.000043428976,0.000086566826,0.00005365996,0.0003927541,0.97337884,0.0003979538,0.0009996636,0.018887887],"study_design_scores_gemma":[0.0005018968,0.011734383,0.005285929,0.00001975517,0.00010761971,0.0003185053,0.000080071106,0.0019298353,0.97400427,0.00018466929,0.005814985,0.000018004535],"about_ca_topic_score_codex":0.0031743406,"about_ca_topic_score_gemma":0.0059697437,"teacher_disagreement_score":0.005713861,"about_ca_system_score_codex":0.00034020533,"about_ca_system_score_gemma":0.0009535341,"threshold_uncertainty_score":0.019114733},"labels":[],"label_agreement":null},{"id":"W2619778898","doi":"10.1016/j.jbo.2017.05.002","title":"Schwannoma of the femur: A rare case report","year":2017,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Schwannoma; Soft tissue; Lesion; Radiology; Magnetic resonance imaging; Benignity; Thigh; Femur; Pathology; Surgery; Malignancy","score_opus":0.03936562956129016,"score_gpt":0.33977824468197,"score_spread":0.30041261512067985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619778898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94545853,0.029866302,0.006580515,0.0039423625,0.0009219262,0.0003215748,0.0007698403,0.00043501038,0.011703943],"genre_scores_gemma":[0.987369,0.005378798,0.0026685984,0.00089157285,0.0015650904,0.00005690187,0.0002009957,0.000040938667,0.0018280607],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988186,0.00011338935,0.00018118149,0.0003018222,0.00020590928,0.00037909372],"domain_scores_gemma":[0.9974388,0.0005139704,0.0007768497,0.00024692024,0.00016314423,0.00086040277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004355722,0.0028295857,0.002060603,0.004498779,0.0036148129,0.0023711303,0.0019193746,0.0077676736,0.004716448],"category_scores_gemma":[0.0034746658,0.0016115092,0.0011339503,0.0031718728,0.0027155548,0.0027720768,0.0028518795,0.0027142018,0.001836873],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019253324,0.000026031072,0.0037526917,0.00004025071,0.000010487756,0.99444556,0.00009213391,0.000034969493,0.00032793282,0.00009121767,0.000236711,0.0009227193],"study_design_scores_gemma":[0.0000058147943,0.000022361559,0.001188867,0.000011029911,0.0000069101397,0.99818975,0.0000697435,0.000042188967,0.00007835305,0.00008591893,0.00029320325,0.000005770533],"about_ca_topic_score_codex":0.002417589,"about_ca_topic_score_gemma":0.004372185,"teacher_disagreement_score":0.0077676736,"about_ca_system_score_codex":0.001294696,"about_ca_system_score_gemma":0.0012706649,"threshold_uncertainty_score":0.015778124},"labels":[],"label_agreement":null},{"id":"W2767480081","doi":"10.1016/j.jbo.2017.11.001","title":"Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer","year":2017,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa; Ottawa Hospital","funders":"American Society of Clinical Oncology","keywords":"Medicine; Zoledronic acid; N-terminal telopeptide; Bone resorption; Bisphosphonate; Internal medicine; Bone sialoprotein; Breast cancer; Bone metastasis; Bone remodeling; Oncology; Cancer; Urology; Gastroenterology; Surgery; Osteoporosis; Osteocalcin; Alkaline phosphatase","score_opus":0.009342403223449125,"score_gpt":0.30040114567634674,"score_spread":0.2910587424528976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767480081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985582,0.00082770817,0.00004702499,0.00008383079,0.00001817618,0.00008704263,0.00006591416,0.000008907727,0.00030311235],"genre_scores_gemma":[0.9992212,0.00021105228,0.00015407774,0.0000965169,0.000024317082,0.00009241283,0.00008921443,0.0000011427841,0.00011007628],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99955875,0.00020126272,0.000037901427,0.000054316555,0.00005505487,0.00009273721],"domain_scores_gemma":[0.998672,0.00054862717,0.00033798616,0.00006399319,0.00005010023,0.00032733855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001094934,0.00033530602,0.0012329803,0.00020009949,0.00017534419,0.00038086233,0.0002498111,0.00048324204,0.0013182046],"category_scores_gemma":[0.0023269309,0.00014300493,0.00075161824,0.00021925446,0.0002760018,0.00022863048,0.00020713876,0.0010284915,0.00015281976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7090798,0.012465891,0.08293156,0.00058595784,0.0017349258,0.00019318139,0.00027791192,0.0015227083,0.02263718,0.000084817824,0.00059377874,0.1678923],"study_design_scores_gemma":[0.10584212,0.6120209,0.27145642,0.00006643081,0.0019377803,0.00041388953,0.00013606065,0.0021530162,0.0044575296,0.00023896272,0.0012393434,0.000037551268],"about_ca_topic_score_codex":0.0006764524,"about_ca_topic_score_gemma":0.0017564279,"teacher_disagreement_score":0.0013182046,"about_ca_system_score_codex":0.00035597934,"about_ca_system_score_gemma":0.0004898856,"threshold_uncertainty_score":0.005790651},"labels":[],"label_agreement":null},{"id":"W3020142787","doi":"10.1016/j.jbo.2020.100289","title":"Local surgical complication rates in patients receiving surgery without immediate post-operative radiation therapy for lower extremity bone metastases","year":2020,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Surgery; Radiation therapy; Complication; Retrospective cohort study","score_opus":0.038799923180043765,"score_gpt":0.34200042953459237,"score_spread":0.3032005063545486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020142787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924517,0.00036051503,0.000056204848,0.000023390754,0.0000034184197,0.0000058244073,0.00008203879,0.0000022830664,0.0002210974],"genre_scores_gemma":[0.9997187,0.00009811604,0.000031291238,0.000010235584,0.000004304197,0.000004224438,0.00008283959,8.0530214e-7,0.000049426828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996644,0.00006419755,0.00005632831,0.00004978661,0.00010798438,0.000057296387],"domain_scores_gemma":[0.9978765,0.0004052026,0.0013052555,0.000055914166,0.00012751012,0.00022948429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028121273,0.00011510415,0.00020268466,0.00051739794,0.0002324079,0.00031061465,0.0002006505,0.00019686903,0.0018341324],"category_scores_gemma":[0.0022957418,0.000103892846,0.00024954733,0.00054881966,0.00026420737,0.00018324493,0.00023138817,0.00036956233,0.0001406085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007066097,0.00002310506,0.9977767,0.000011762382,0.0000137642655,0.00025312317,0.000024490957,0.000035364108,0.00011935365,0.000006342486,0.000050314524,0.0016150388],"study_design_scores_gemma":[0.0000076164324,0.00026679318,0.996425,0.000010995488,0.000018469394,0.0027633195,0.00013237383,0.000080600796,0.00016703995,0.00001125975,0.00011332429,0.0000032708137],"about_ca_topic_score_codex":0.0012980384,"about_ca_topic_score_gemma":0.0021685625,"teacher_disagreement_score":0.0018341324,"about_ca_system_score_codex":0.000343336,"about_ca_system_score_gemma":0.00031200427,"threshold_uncertainty_score":0.0061357617},"labels":[],"label_agreement":null},{"id":"W3046375573","doi":"10.1016/j.jbo.2020.100311","title":"Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group","year":2020,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Royal Osteoporosis Society; Prostate Cancer UK; British Geriatrics Society; National Institute for Health and Care Research; European Association of Urology; National Comprehensive Cancer Network; National Institute for Health and Care Excellence; American Society of Clinical Oncology; European SocieTy for Radiotherapy and Oncology; Amgen; Cancer Care Ontario","keywords":"Medicine; Androgen deprivation therapy; FRAX; Guideline; Osteoporosis; Prostate cancer; Context (archaeology); Population; Physical therapy; Intensive care medicine; Cancer; Internal medicine; Bone mineral; Pathology; Environmental health","score_opus":0.06632793964267818,"score_gpt":0.4236422353138292,"score_spread":0.357314295671151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046375573","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014906835,0.34798566,0.020839041,0.5457983,0.027139578,0.0077742795,0.0073587084,0.0007991516,0.04081455],"genre_scores_gemma":[0.020795286,0.49255386,0.18781812,0.20161264,0.011665426,0.020171337,0.020912783,0.0005291706,0.04394147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97659427,0.010527992,0.004482456,0.0010552377,0.0064075137,0.0009325402],"domain_scores_gemma":[0.9529739,0.013537579,0.00494567,0.0007620766,0.025332669,0.0024480869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03142474,0.0018991267,0.0028747388,0.0054336623,0.0013999103,0.0035439446,0.007433222,0.014031681,0.011503181],"category_scores_gemma":[0.056507293,0.0014869891,0.00649502,0.0030079372,0.0016058045,0.0032339138,0.0046708076,0.00692746,0.011314165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008143007,0.00009192927,0.0004385065,0.017107725,0.00013970124,0.00034104296,0.0005812309,0.0004337773,0.00042758347,0.002349297,0.7500704,0.22793742],"study_design_scores_gemma":[0.00024770029,0.0001195414,0.0017146337,0.079174146,0.00034958246,0.0007419632,0.00043737856,0.00037200848,0.00023270062,0.005653041,0.91088146,0.00007570811],"about_ca_topic_score_codex":0.015771396,"about_ca_topic_score_gemma":0.01759012,"teacher_disagreement_score":0.03142474,"about_ca_system_score_codex":0.0057086432,"about_ca_system_score_gemma":0.024597328,"threshold_uncertainty_score":0.16619194},"labels":[],"label_agreement":null},{"id":"W3087567806","doi":"10.1016/j.jbo.2020.100319","title":"Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Amputation; Osteosarcoma; Meta-analysis; Odds ratio; Surgery; Confidence interval; Neoadjuvant therapy; Chemotherapy; Internal medicine; Cancer; Pathology; Breast cancer","score_opus":0.043891256370891266,"score_gpt":0.31356244292492974,"score_spread":0.2696711865540385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087567806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059116166,0.99293,0.00023973727,0.00017737862,0.00012683294,0.000117968215,0.00027838003,0.00001437036,0.00020365475],"genre_scores_gemma":[0.27276656,0.7214204,0.00167371,0.0016981581,0.000498854,0.00059135666,0.0008614018,0.00004164789,0.00044795347],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927256,0.003345533,0.002303651,0.00076463725,0.0006603407,0.00020018694],"domain_scores_gemma":[0.9850677,0.011053823,0.0024422463,0.00040826798,0.00079126394,0.00023668363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010250488,0.0020140172,0.012649467,0.00518162,0.00052147,0.0027902261,0.0013195222,0.0021256113,0.003142872],"category_scores_gemma":[0.021683972,0.001275246,0.04095091,0.0048639285,0.0006560305,0.0014952873,0.00094664446,0.0016116389,0.00028370778],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003550361,0.00004164851,0.006750718,0.27472925,0.70203537,0.00015101227,0.000075231954,0.00029558985,0.00027846036,0.00007590521,0.00048896676,0.011527451],"study_design_scores_gemma":[0.0005591053,0.00022891967,0.0047848406,0.010301514,0.98275995,0.0000939007,0.00002921435,0.000093059934,0.000070444235,0.000086482774,0.00097608083,0.000016444032],"about_ca_topic_score_codex":0.004875716,"about_ca_topic_score_gemma":0.013493985,"teacher_disagreement_score":0.012649467,"about_ca_system_score_codex":0.0017247612,"about_ca_system_score_gemma":0.0020920646,"threshold_uncertainty_score":0.054210424},"labels":[],"label_agreement":null},{"id":"W3105015606","doi":"10.1016/j.jbo.2020.100339","title":"Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey","year":2020,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital","keywords":"Medicine; Prostate cancer; Breast cancer; Bone metastasis; Oncology; De-escalation; Prostate; Internal medicine; Cancer; Gynecology","score_opus":0.04638116212940865,"score_gpt":0.37246801057634893,"score_spread":0.3260868484469403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105015606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710816,0.00024479697,0.00004957403,0.0007749742,0.0000040349073,0.000034406654,0.0009238092,0.0000031808497,0.0008571435],"genre_scores_gemma":[0.99863416,0.00029467908,0.00016970786,0.00032663604,0.0000074774434,0.00002119778,0.00037851962,0.0000014113408,0.00016617546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851555,0.00042504276,0.00018228739,0.00016726418,0.0004534929,0.0002563958],"domain_scores_gemma":[0.992328,0.001403426,0.0032967166,0.00013679673,0.0012931963,0.0015418463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013297145,0.00008956558,0.00018687447,0.00066371314,0.00071001914,0.0006764637,0.0003132474,0.0005070248,0.0015274036],"category_scores_gemma":[0.005803294,0.00018559807,0.0002499276,0.001584811,0.0004630858,0.000465386,0.00045844004,0.00048406378,0.00021010535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031264735,0.000033945184,0.9959203,0.000029955376,0.000012301085,0.000053505326,0.0013660608,0.00004055928,0.000067548564,0.0000106164825,0.00048801393,0.0019458813],"study_design_scores_gemma":[0.000007904748,0.00007771667,0.99487656,0.000029908433,0.0000071254385,0.00015003773,0.003846853,0.00017297703,0.000028540351,0.000006875496,0.00078867545,0.0000068869017],"about_ca_topic_score_codex":0.41719124,"about_ca_topic_score_gemma":0.5165913,"teacher_disagreement_score":0.41719124,"about_ca_system_score_codex":0.0034809457,"about_ca_system_score_gemma":0.0036836383,"threshold_uncertainty_score":0.8295258},"labels":[],"label_agreement":null},{"id":"W3112097954","doi":"10.1016/j.jbo.2020.100343","title":"Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer","year":2020,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Markham Stouffville Hospital; McMaster University; Juravinski Hospital; Western University; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital; Seattle Genetics; Acadia University; Roche; Cure JM Foundation; American Society of Clinical Oncology; Novartis; Ottawa Hospital Foundation; Pfizer","keywords":"Medicine; Dosing; Breast cancer; Adjuvant; Internal medicine; Randomized controlled trial; Cancer; Clinical trial; Stage (stratigraphy); Clinical endpoint; Oncology","score_opus":0.045297879997038666,"score_gpt":0.31921066338911874,"score_spread":0.2739127833920801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112097954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97178024,0.0013387863,0.0009909339,0.00090330595,0.00056694867,0.022228632,0.00073774846,0.000048994498,0.0014045435],"genre_scores_gemma":[0.9700465,0.00063020404,0.0032344607,0.00071628817,0.00055206806,0.022819424,0.0007305623,0.000016430497,0.0012541432],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99236965,0.005647512,0.0005231592,0.00054984796,0.00029537702,0.0006144841],"domain_scores_gemma":[0.9851354,0.0057987226,0.003959525,0.0012723423,0.0010043348,0.0028297422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012175073,0.0018904347,0.0031316665,0.00067629485,0.0007805062,0.0012274459,0.0013777136,0.00312425,0.007180634],"category_scores_gemma":[0.015800452,0.0010812789,0.0038226799,0.000685107,0.0023854668,0.0021154287,0.0015523562,0.002905877,0.0013117109],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98817295,0.007027452,0.0005848535,0.00015167025,0.00026745858,0.000024516114,0.000044585315,0.00018848325,0.0005139695,0.00003564142,0.00011622918,0.0028722193],"study_design_scores_gemma":[0.75373524,0.24375774,0.0016530125,0.000015038774,0.00022341977,0.000020416115,0.000024632172,0.00015770025,0.00012061964,0.00010495909,0.00017619347,0.00001102508],"about_ca_topic_score_codex":0.0011744547,"about_ca_topic_score_gemma":0.001660925,"teacher_disagreement_score":0.012175073,"about_ca_system_score_codex":0.0017627161,"about_ca_system_score_gemma":0.0038524035,"threshold_uncertainty_score":0.06438869},"labels":[],"label_agreement":null},{"id":"W3112306160","doi":"10.1016/j.jbo.2020.100345","title":"Bone cement as a local chemotherapeutic drug delivery carrier in orthopedic oncology: A review","year":2020,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Michael's Hospital; Toronto Metropolitan University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Orthopedic surgery; Bone cement; Chemotherapy; Radiation therapy; Drug; Chemotherapeutic drugs; Internal medicine; Oncology; Surgery; Pharmacology; Cement","score_opus":0.05195295076585692,"score_gpt":0.39620765957292825,"score_spread":0.3442547088070713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112306160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011330513,0.99938536,0.00003829718,0.00007361327,0.00007218753,0.0000034160407,0.0000070867254,0.0000022450745,0.00030437362],"genre_scores_gemma":[0.0005419188,0.9991179,0.00009582387,0.000053159278,0.000052389205,0.000003324721,0.000009607903,6.2822807e-7,0.00012512898],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997782,0.00003865214,0.000048437436,0.000036858008,0.00008185749,0.000015966894],"domain_scores_gemma":[0.9994524,0.00032399056,0.00009566143,0.000009363674,0.00009287479,0.000025577008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005276461,0.00079416943,0.0011396995,0.0033591224,0.00029102026,0.0009967877,0.0006474362,0.0009274653,0.0029900882],"category_scores_gemma":[0.0008585868,0.00033451035,0.0005804299,0.0030616086,0.00040706928,0.0011559883,0.0004463749,0.0009507273,0.0008333804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007243741,0.00010917985,0.0003196756,0.064835064,0.00014501132,0.00026409165,0.000094573465,0.0003993174,0.002225605,0.002109159,0.018014848,0.91141105],"study_design_scores_gemma":[0.000023279044,0.00020517479,0.0016606989,0.015318385,0.00042876642,0.002761907,0.00010263402,0.00017326885,0.0009100596,0.0010078986,0.9773796,0.00002822581],"about_ca_topic_score_codex":0.0013834033,"about_ca_topic_score_gemma":0.0023888338,"teacher_disagreement_score":0.0033591224,"about_ca_system_score_codex":0.00042332304,"about_ca_system_score_gemma":0.0013770105,"threshold_uncertainty_score":0.0100028515},"labels":[],"label_agreement":null},{"id":"W3129409729","doi":"10.1016/j.jbo.2021.100351","title":"Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation","year":2021,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Research Institute","keywords":"Medicine; Bisphosphonate; Breast cancer; Adjuvant; Internal medicine; Clinical trial; Oncology; Cancer; Surgery; Osteoporosis","score_opus":0.010663910090091298,"score_gpt":0.2879778522623766,"score_spread":0.2773139421722853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129409729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909264,0.0016851658,0.0001438929,0.0037663365,0.000016389473,0.000019921039,0.000055060904,0.000003536288,0.0033833256],"genre_scores_gemma":[0.9986588,0.00060645514,0.00010975642,0.00050262513,0.000019456422,0.0000073472,0.000019714364,9.42069e-7,0.00007490758],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99496245,0.0036777586,0.0003450802,0.000093391245,0.0006502123,0.00027114083],"domain_scores_gemma":[0.98642576,0.008336555,0.0035415508,0.00010557862,0.00084940245,0.0007411645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005000545,0.00009272711,0.0002364501,0.0003169354,0.0005038521,0.0013571093,0.000197045,0.0006052969,0.0020525428],"category_scores_gemma":[0.020466374,0.00010729206,0.0004467342,0.00039975063,0.00050038117,0.0007745875,0.0005944972,0.0008274726,0.00015915802],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013191601,0.00039838415,0.8692943,0.0005557466,0.00021759656,0.000903476,0.027150707,0.00039098525,0.0013303872,0.00064227666,0.0027102872,0.09508667],"study_design_scores_gemma":[0.00023646488,0.00307874,0.88564324,0.0006519654,0.00032480116,0.006307165,0.08233916,0.0021315417,0.0011757815,0.001252745,0.016742308,0.000116157855],"about_ca_topic_score_codex":0.0016683453,"about_ca_topic_score_gemma":0.0020479886,"teacher_disagreement_score":0.005000545,"about_ca_system_score_codex":0.00066709064,"about_ca_system_score_gemma":0.0006806452,"threshold_uncertainty_score":0.026445746},"labels":[],"label_agreement":null},{"id":"W3157212746","doi":"10.1016/j.jbo.2021.100361","title":"Osteoporosis management in hematologic stem cell transplant recipients: Executive summary","year":2021,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Shire; Meso Scale Diagnostics; Instituto de Salud Carlos III; Novartis; Amgen; Pfizer; AstraZeneca; European Regional Development Fund; Universidad de Oviedo; Eli Lilly and Company; Astellas Pharma US","keywords":"Medicine; Osteoporosis; Intensive care medicine; Fragility fracture; Hematopoietic stem cell; Adverse effect; Hematopoietic stem cell transplantation; Stem cell; Internal medicine; Transplantation; Bone mineral; Haematopoiesis","score_opus":0.07027376826481813,"score_gpt":0.3971334928889796,"score_spread":0.32685972462416146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157212746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011750555,0.9975746,0.000053152846,0.00074614864,0.00041899778,0.000029377034,0.0001811425,0.000007391822,0.0008716073],"genre_scores_gemma":[0.00063169556,0.9978815,0.00017453237,0.00044605247,0.00025923803,0.000022311824,0.00021602081,0.0000012727409,0.0003673154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960023,0.000099349665,0.00011578689,0.000037047863,0.00012244435,0.000025089364],"domain_scores_gemma":[0.99914134,0.0003503359,0.00024976756,0.000012781469,0.00020954075,0.00003624244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011586397,0.00072466244,0.0015235991,0.0020510186,0.00020042487,0.0009724063,0.0008267305,0.0010067233,0.0071659633],"category_scores_gemma":[0.002347535,0.0002847424,0.0011204046,0.0017667961,0.00012889903,0.0006359111,0.00043531053,0.001088388,0.0014432438],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016747162,0.000049713864,0.00024427281,0.10929476,0.00039471695,0.00007274576,0.000047213394,0.00017763619,0.00026020294,0.0006038864,0.078389995,0.8102973],"study_design_scores_gemma":[0.00019756098,0.00026008283,0.0037939954,0.2061334,0.0025684058,0.00076146174,0.00009610335,0.00012949249,0.00030951708,0.00084378937,0.78487724,0.000028972265],"about_ca_topic_score_codex":0.002605727,"about_ca_topic_score_gemma":0.005663041,"teacher_disagreement_score":0.0071659633,"about_ca_system_score_codex":0.0005079669,"about_ca_system_score_gemma":0.0017508769,"threshold_uncertainty_score":0.02397257},"labels":[],"label_agreement":null},{"id":"W3197710270","doi":"10.1016/j.jbo.2021.100388","title":"Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer","year":2021,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; University of Alberta; Western University; London Health Sciences Centre; McMaster University; University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research; Government of Ontario; Ottawa Hospital Foundation; Cancer Care Ontario; American Society of Clinical Oncology","keywords":"Medicine; Prostate cancer; Denosumab; Hazard ratio; Breast cancer; Internal medicine; Bone metastasis; Oncology; Osteoporosis; Cancer; Confidence interval","score_opus":0.058775849652154696,"score_gpt":0.3408792335917592,"score_spread":0.2821033839396045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197710270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98860264,0.00483634,0.0006031503,0.0007939781,0.0008058752,0.0021577708,0.000980126,0.000053185027,0.0011668886],"genre_scores_gemma":[0.98576593,0.0019230843,0.0013331108,0.0010205867,0.000824536,0.0037823364,0.0016783631,0.000023493032,0.0036484853],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99533045,0.003333198,0.0003200152,0.0004014342,0.00019506454,0.0004199206],"domain_scores_gemma":[0.99363685,0.002741446,0.0015257559,0.00049923535,0.0003465648,0.001250194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006458626,0.0023571039,0.0046703843,0.00064294436,0.0005113961,0.0012993192,0.0011576148,0.004145895,0.010679446],"category_scores_gemma":[0.008658258,0.0011525276,0.0060089733,0.00062160165,0.0014466702,0.0020159984,0.0009193587,0.0038430658,0.0010787294],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9928813,0.0022422418,0.00029837768,0.00019925354,0.000733538,0.000022725486,0.000018972394,0.00021556899,0.00052206294,0.000020031297,0.00012070813,0.0027252126],"study_design_scores_gemma":[0.9207913,0.07575884,0.0018731134,0.000028615399,0.00080715877,0.000020235218,0.000013857128,0.00020151534,0.00015444132,0.000062457984,0.0002736002,0.000014889173],"about_ca_topic_score_codex":0.0012069151,"about_ca_topic_score_gemma":0.002053037,"teacher_disagreement_score":0.010679446,"about_ca_system_score_codex":0.0012450247,"about_ca_system_score_gemma":0.0012591375,"threshold_uncertainty_score":0.03572631},"labels":[],"label_agreement":null},{"id":"W3205182700","doi":"10.1016/j.jbo.2021.100397","title":"Frequency and reason for reoperation following non-invasive expandable endoprostheses: A systematic review","year":2021,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Implant; Implant failure; Surgery; Cochrane Library; Prosthesis; Tibia; Randomized controlled trial","score_opus":0.05253528624680771,"score_gpt":0.39462655660264906,"score_spread":0.34209127035584136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205182700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031635722,0.99578,0.00005998506,0.000104104336,0.00005415133,0.00009475139,0.00054693467,0.0000047083777,0.00019179226],"genre_scores_gemma":[0.029326476,0.96916664,0.00024791973,0.00034503508,0.0000813751,0.0002379571,0.0004579138,0.0000058801215,0.00013080373],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99618125,0.0007598582,0.0018981695,0.00039202298,0.0006526822,0.0001160983],"domain_scores_gemma":[0.97599864,0.016233895,0.005870963,0.0002441778,0.001459685,0.00019262082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003251527,0.000892238,0.005970267,0.007878376,0.00039659673,0.0017313039,0.0014929026,0.0014447,0.0041155405],"category_scores_gemma":[0.020811152,0.00069395354,0.0072412295,0.009106444,0.000650971,0.0018760212,0.00090206065,0.0008115418,0.00027730825],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032625286,0.000019465022,0.0043942733,0.9578299,0.00873851,0.00021657378,0.00021467436,0.000054226955,0.00011666089,0.000091555085,0.0012608116,0.026737155],"study_design_scores_gemma":[0.00040255184,0.00040287292,0.033928894,0.8447834,0.0971994,0.0025285198,0.0007868728,0.00011261108,0.00024343462,0.00025014827,0.019291513,0.00006974133],"about_ca_topic_score_codex":0.004376357,"about_ca_topic_score_gemma":0.0108475685,"teacher_disagreement_score":0.007878376,"about_ca_system_score_codex":0.0017391425,"about_ca_system_score_gemma":0.0041934415,"threshold_uncertainty_score":0.01719588},"labels":[],"label_agreement":null},{"id":"W4213176775","doi":"10.1016/j.jbo.2022.100416","title":"Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval","year":2022,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Amgen; National Multiple Sclerosis Society Michigan Chapter","keywords":"Denosumab; Medicine; Discontinuation; Multiple myeloma; Zoledronic acid; Dosing; Oncology; Osteonecrosis of the jaw; Bisphosphonate; Pathologic fracture; Internal medicine; Surgery; Osteoporosis","score_opus":0.06026342711057341,"score_gpt":0.4142754096047931,"score_spread":0.35401198249421967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213176775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10393226,0.6495483,0.011382544,0.08511931,0.007074211,0.00053738034,0.0012010519,0.0005094889,0.14069551],"genre_scores_gemma":[0.4899521,0.34861055,0.0073398664,0.09485374,0.008300503,0.00038370263,0.003543037,0.0003657041,0.046650812],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979919,0.0006366091,0.00022436061,0.00021875321,0.00062708376,0.00030121513],"domain_scores_gemma":[0.99706286,0.0009727924,0.0004828679,0.0001626196,0.0006110802,0.0007077829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078077028,0.00041025854,0.0006149925,0.00047058548,0.00056517276,0.0020436447,0.00062291464,0.0015542752,0.006284974],"category_scores_gemma":[0.0072931363,0.00017971329,0.00086268055,0.0007474618,0.00064361934,0.0014739388,0.00086290657,0.003899361,0.002425949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018704549,0.00092561,0.008932326,0.0011085181,0.000248097,0.0017109861,0.00089740916,0.0005420784,0.004152907,0.008225839,0.10261361,0.8687722],"study_design_scores_gemma":[0.00080780376,0.002809174,0.011452228,0.0010293006,0.0001571148,0.0043095606,0.00022445232,0.00022706561,0.0018314208,0.0014224176,0.97569704,0.00003231375],"about_ca_topic_score_codex":0.0011681286,"about_ca_topic_score_gemma":0.0022210618,"teacher_disagreement_score":0.0078077028,"about_ca_system_score_codex":0.0009443662,"about_ca_system_score_gemma":0.0011204632,"threshold_uncertainty_score":0.041291595},"labels":[],"label_agreement":null},{"id":"W4220868834","doi":"10.1016/j.jbo.2022.100423","title":"Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach","year":2022,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Amgen","keywords":"Denosumab; Medicine; Discontinuation; Internal medicine; Oncology; Context (archaeology); Incidence (geometry); Osteoporosis","score_opus":0.017731100551531057,"score_gpt":0.28611466755565623,"score_spread":0.2683835670041252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220868834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960129,0.00032045125,0.0018140911,0.00025479376,0.0000083497225,0.000036107398,0.0012884673,0.000016109836,0.00024873298],"genre_scores_gemma":[0.99755424,0.00007451745,0.001154212,0.000027982951,0.000012587081,0.000025303236,0.001076508,0.0000017321032,0.00007287787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984707,0.00076219667,0.00019532703,0.00029925435,0.00017398513,0.00009852328],"domain_scores_gemma":[0.9914692,0.0046623587,0.0027219725,0.00049929565,0.00039703413,0.00025017525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028440806,0.00023833051,0.00038955334,0.0012778084,0.00021676715,0.0005571208,0.000507481,0.00041688656,0.0012604971],"category_scores_gemma":[0.01082514,0.000151585,0.0011841903,0.0011849124,0.00018201691,0.00041917973,0.00048527794,0.0007818148,0.000141684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028500392,0.00007023034,0.9935021,0.000026680262,0.00017062823,0.000040854662,0.00002765641,0.0011289256,0.00006516676,0.000049196075,0.00017414032,0.0044595],"study_design_scores_gemma":[0.00004104643,0.00038806093,0.9588348,0.000031411568,0.00022777414,0.00029904474,0.00013693265,0.038973268,0.00015800823,0.00048025616,0.0004141255,0.00001530612],"about_ca_topic_score_codex":0.0018461979,"about_ca_topic_score_gemma":0.0031302837,"teacher_disagreement_score":0.0028440806,"about_ca_system_score_codex":0.00034896086,"about_ca_system_score_gemma":0.00047369397,"threshold_uncertainty_score":0.015041113},"labels":[],"label_agreement":null},{"id":"W4224307447","doi":"10.1016/j.jbo.2022.100428","title":"Joint-sparing reconstruction for extensive periacetabular metastases: Literature review and a novel minimally invasive surgical technique","year":2022,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Surgery; Percutaneous; Cryoablation; Acetabulum; Minimally invasive procedures","score_opus":0.06996423204068355,"score_gpt":0.3680374689734899,"score_spread":0.2980732369328063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224307447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018094527,0.9993168,0.00006481317,0.00008933647,0.000053936496,0.0000026754092,0.000007175379,0.0000028793509,0.0002814902],"genre_scores_gemma":[0.000839126,0.9987822,0.00012354442,0.00006952556,0.000092018345,0.0000027415697,0.000013262568,7.923245e-7,0.00007671757],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998192,0.000026038122,0.00005418159,0.000037248512,0.00005141594,0.000011932119],"domain_scores_gemma":[0.9995347,0.00027295397,0.00009123033,0.000011410161,0.00006735826,0.000022387529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047822116,0.00077851873,0.0012689021,0.003557218,0.00034236803,0.0008441085,0.0009867897,0.00069768494,0.0025559838],"category_scores_gemma":[0.0009438306,0.00026123962,0.0007409507,0.0037135512,0.0005865163,0.0012549745,0.00048768675,0.00101122,0.00065156777],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007972056,0.00009490653,0.00070435216,0.047543764,0.00022184147,0.00094358757,0.000118067364,0.00033697445,0.0010426113,0.0012090346,0.014189015,0.93351614],"study_design_scores_gemma":[0.00006754048,0.0005025679,0.008728634,0.043880597,0.001871397,0.036088284,0.0004980749,0.00044773042,0.0014887841,0.0032864092,0.90305066,0.00008926198],"about_ca_topic_score_codex":0.0011177134,"about_ca_topic_score_gemma":0.0022170437,"teacher_disagreement_score":0.003557218,"about_ca_system_score_codex":0.00033002056,"about_ca_system_score_gemma":0.00097374455,"threshold_uncertainty_score":0.008550644},"labels":[],"label_agreement":null},{"id":"W4280500335","doi":"10.1016/j.jbo.2022.100432","title":"Focal adhesion kinase inhibitors prevent osteoblast mineralization in part due to suppression of Akt-mediated stabilization of osterix","year":2022,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Canadian Cancer Society","keywords":"RUNX2; Osteoblast; Medicine; Focal adhesion; Protein kinase B; Cancer research; Osteolysis; Phosphorylation; Alkaline phosphatase; Cell biology; Internal medicine; Endocrinology; Chemistry; Biology; Biochemistry; In vitro; Surgery; Enzyme","score_opus":0.020385246762433057,"score_gpt":0.31690761275713736,"score_spread":0.2965223659947043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280500335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824553,0.0058996296,0.004655362,0.00034141715,0.000163367,0.00015275899,0.0010559608,0.00016394933,0.0051122475],"genre_scores_gemma":[0.98019654,0.004259552,0.003268362,0.000069733396,0.000023746486,0.0001908072,0.0016140983,0.000023873805,0.010353234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996934,0.00003375936,0.000028511748,0.000044906465,0.00012527428,0.000074196854],"domain_scores_gemma":[0.99991894,0.0000122557885,0.000027946086,0.000009743845,0.00001111415,0.000020070405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022887671,0.00068820495,0.00041890985,0.00045026297,0.0002489269,0.00030911833,0.00032751405,0.00031160202,0.0028293908],"category_scores_gemma":[0.000081091275,0.00029840934,0.00044380507,0.00032604046,0.00030232014,0.000216867,0.00022527669,0.0011481593,0.00043355505],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027812898,0.00016519144,0.00011347455,0.0001189304,0.000017747596,0.000050421928,0.000012088551,0.00009547044,0.9970975,0.00015248569,0.00011261888,0.001786022],"study_design_scores_gemma":[0.000061062216,0.0013654794,0.0027530657,0.000006499689,0.000029434192,0.00020638417,0.000025355717,0.00057636364,0.9921233,0.00005573305,0.002793222,0.0000041963226],"about_ca_topic_score_codex":0.0014116956,"about_ca_topic_score_gemma":0.0036932619,"teacher_disagreement_score":0.0028293908,"about_ca_system_score_codex":0.0003764688,"about_ca_system_score_gemma":0.0005373447,"threshold_uncertainty_score":0.009465277},"labels":[],"label_agreement":null},{"id":"W4283703268","doi":"10.1016/j.jbo.2022.100443","title":"The 100 most cited papers on bone metastasis: A bibliometric analysis","year":2022,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bibliometrics; Bone metastasis; MEDLINE; Metastasis; Library science; Internal medicine; Cancer","score_opus":0.09770212561842304,"score_gpt":0.4139583733676054,"score_spread":0.3162562477491824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283703268","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42301542,0.45145267,0.012157359,0.0037678895,0.00096124475,0.0031675692,0.06541667,0.00091578224,0.039145384],"genre_scores_gemma":[0.6782333,0.26179084,0.024946826,0.0003355358,0.0010313598,0.0024342646,0.026276924,0.00015406431,0.004796852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99235594,0.0010908343,0.0018436493,0.00065756775,0.003713795,0.0003381183],"domain_scores_gemma":[0.9827015,0.009344436,0.0029341606,0.00038721305,0.004223081,0.00040968775],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.005943449,0.0010989588,0.0022949413,0.1196447,0.0013433677,0.003960304,0.0010420072,0.0007819445,0.0048207687],"category_scores_gemma":[0.025603408,0.00034051033,0.0025840679,0.113769114,0.00063108164,0.0023231923,0.0016478546,0.00048544168,0.0012785748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000662156,0.00024667097,0.24087165,0.0962043,0.00553242,0.0024020073,0.0042652003,0.0023055454,0.0049051773,0.004205948,0.03436487,0.604034],"study_design_scores_gemma":[0.00019282833,0.0006317143,0.6266863,0.028470356,0.019596746,0.0084559275,0.01074342,0.008246174,0.0070487675,0.011290555,0.27826044,0.00037680773],"about_ca_topic_score_codex":0.002542897,"about_ca_topic_score_gemma":0.0037635523,"teacher_disagreement_score":0.8803553,"about_ca_system_score_codex":0.0017262339,"about_ca_system_score_gemma":0.0038118982,"threshold_uncertainty_score":0.03143233},"labels":[],"label_agreement":null},{"id":"W4319756910","doi":"10.1016/j.jbo.2023.100469","title":"Surgical margin assessment of bone tumours: A systematic review of current and emerging technologies","year":2023,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Margin (machine learning); Current (fluid); Medical physics; Radiology","score_opus":0.09639886831914976,"score_gpt":0.4636447641933775,"score_spread":0.36724589587422773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319756910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055173895,0.9988331,0.000080875456,0.00011946635,0.00004669241,0.000079761434,0.00015477648,0.0000033216822,0.00013024578],"genre_scores_gemma":[0.0062720953,0.9926472,0.0004307727,0.00022808062,0.000060764472,0.0001568652,0.00014774072,0.0000035476999,0.000053006745],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9923881,0.0020054409,0.003438145,0.0005207825,0.0014878658,0.000159723],"domain_scores_gemma":[0.9601686,0.029402638,0.006629416,0.00048058096,0.0030479638,0.00027074027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008765787,0.00129349,0.0058970787,0.013768585,0.000518342,0.0023510475,0.0017378838,0.0014888417,0.003410195],"category_scores_gemma":[0.03314449,0.0008626197,0.0057952604,0.012037136,0.00085327256,0.0022845806,0.0012544779,0.0008443821,0.00031556352],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013477053,0.000012214969,0.0007205939,0.9521675,0.003519329,0.000090143636,0.00014152103,0.0000666735,0.00016634385,0.00013084001,0.0009702233,0.041879915],"study_design_scores_gemma":[0.00010133371,0.00023166092,0.004619123,0.93508667,0.039146423,0.0005719404,0.0002547449,0.000070396,0.00018805488,0.00023695182,0.019460168,0.0000324268],"about_ca_topic_score_codex":0.0045797513,"about_ca_topic_score_gemma":0.018093439,"teacher_disagreement_score":0.013768585,"about_ca_system_score_codex":0.0023771804,"about_ca_system_score_gemma":0.007594081,"threshold_uncertainty_score":0.046358466},"labels":[],"label_agreement":null},{"id":"W4319769773","doi":"10.1016/j.jbo.2023.100470","title":"Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis","year":2023,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"McGill University Health Centre; Réseau de Recherche en Santé Buccodentaire et Osseuse; Cancer Research Society; McGill University","keywords":"Medicine; Zoledronic acid; Meta-analysis; Internal medicine; Placebo; Bone metastasis; Oncology; Randomized controlled trial; Metastasis; Cancer; Pathology","score_opus":0.13453813250420812,"score_gpt":0.4234312327429676,"score_spread":0.28889310023875947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319769773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003915223,0.99283457,0.001575462,0.00028672803,0.00010256103,0.00037653834,0.0006284362,0.0000368043,0.00024369547],"genre_scores_gemma":[0.19011128,0.7990476,0.006323973,0.00085741415,0.00026305357,0.0017347479,0.001251286,0.000034848126,0.0003757791],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9908963,0.005623545,0.0016670612,0.0007235077,0.0008741222,0.00021546963],"domain_scores_gemma":[0.9839557,0.012903095,0.0017314124,0.00039914213,0.0008442432,0.00016639162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014919176,0.0027697708,0.016444843,0.007891861,0.00047914582,0.0022135074,0.0022525631,0.0017268454,0.0035525516],"category_scores_gemma":[0.028687233,0.0012749594,0.03219468,0.007212874,0.0004519676,0.0014551046,0.0012265688,0.0015048834,0.00029395043],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018529922,0.000039406757,0.0025834157,0.3193007,0.6560648,0.0001309662,0.000059928287,0.0019873136,0.00020445682,0.00026704025,0.000679038,0.01682992],"study_design_scores_gemma":[0.00056414265,0.00018972777,0.002163438,0.019028172,0.9751432,0.00007159149,0.000023653753,0.00082133245,0.000066806504,0.00041208114,0.0014942407,0.000021573394],"about_ca_topic_score_codex":0.0088086985,"about_ca_topic_score_gemma":0.016181678,"teacher_disagreement_score":0.016444843,"about_ca_system_score_codex":0.0026835878,"about_ca_system_score_gemma":0.003647534,"threshold_uncertainty_score":0.07890111},"labels":[],"label_agreement":null},{"id":"W4388211181","doi":"10.1016/j.jbo.2023.100508","title":"A fusion of VGG-16 and ViT models for improving bone tumor classification in computed tomography","year":2023,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Artificial intelligence; Medicine; Deep learning; Convolutional neural network; Pattern recognition (psychology); Segmentation; Machine learning; Computer science","score_opus":0.022973380999573273,"score_gpt":0.27179444175735906,"score_spread":0.2488210607577858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388211181","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45095775,0.0040509836,0.52526116,0.0013074845,0.00050366257,0.00028007285,0.0011798616,0.009815832,0.006643203],"genre_scores_gemma":[0.9173914,0.0005239882,0.0754623,0.00032033143,0.00006014746,0.00008139938,0.0016816931,0.00017664234,0.0043020193],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99973243,0.000036412242,0.000015844815,0.0000812207,0.00006879445,0.00006534543],"domain_scores_gemma":[0.9997074,0.00007322835,0.0000411225,0.000038792237,0.00010773464,0.000031734035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008952074,0.0012247196,0.0008164264,0.0012322582,0.00025899647,0.0008381579,0.0017118598,0.0011102431,0.0012088928],"category_scores_gemma":[0.0016310068,0.00032846557,0.0008548899,0.00083689217,0.00039747808,0.0009630944,0.00092363195,0.0010311519,0.0006685698],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056909147,0.00030776224,0.006510358,0.0001274871,0.00019523251,0.00015623502,0.00007323483,0.5592194,0.015944181,0.0015849775,0.00665375,0.4086583],"study_design_scores_gemma":[0.000009458507,0.00006487584,0.00044872132,0.000007559512,0.000022656155,0.000028650442,0.0000084583835,0.99567765,0.0028350016,0.0004722135,0.00041924082,0.0000056563836],"about_ca_topic_score_codex":0.01249634,"about_ca_topic_score_gemma":0.009979876,"teacher_disagreement_score":0.01249634,"about_ca_system_score_codex":0.0010878589,"about_ca_system_score_gemma":0.0010409193,"threshold_uncertainty_score":0.02484721},"labels":[],"label_agreement":null},{"id":"W4395014703","doi":"10.1016/j.jbo.2024.100603","title":"Incidence, Risk Factors, and Survival of Bone Metastases and Skeletal-Related Events in Melanoma Patients: A Systematic Review and Quality Assessment of 29 Studies","year":2024,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Melanoma; Oncology; Internal medicine; Intensive care medicine; Cancer research","score_opus":0.06591572171073737,"score_gpt":0.41635885871631395,"score_spread":0.3504431370055766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395014703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005504007,0.9904474,0.00044082743,0.00027767397,0.00009019896,0.0010423986,0.0018219606,0.00002026047,0.000355271],"genre_scores_gemma":[0.089925714,0.9010575,0.0025959858,0.00085754663,0.00011077403,0.0035931594,0.00163061,0.000027753418,0.0002010756],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9753287,0.0064617866,0.013154321,0.0015285598,0.0031348225,0.00039182606],"domain_scores_gemma":[0.9179313,0.051977172,0.022439098,0.0014183947,0.0056142947,0.00061972527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019191498,0.0016267628,0.0131586855,0.013960691,0.000937621,0.0030656443,0.00256143,0.0018826867,0.0033688357],"category_scores_gemma":[0.07222792,0.0012946805,0.01312969,0.015185141,0.00138182,0.0022415537,0.0021068298,0.001176775,0.00023385427],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030261453,0.0000130365615,0.0029675618,0.95936984,0.024695128,0.000112155896,0.00019954557,0.00009604526,0.0001307498,0.000094248586,0.00048531237,0.011533711],"study_design_scores_gemma":[0.0005988284,0.00027886563,0.014897201,0.6940993,0.28015462,0.00057404116,0.0004115568,0.00015951961,0.00026396426,0.00030855575,0.008187821,0.00006570947],"about_ca_topic_score_codex":0.0077033127,"about_ca_topic_score_gemma":0.018935502,"teacher_disagreement_score":0.019191498,"about_ca_system_score_codex":0.004825562,"about_ca_system_score_gemma":0.008839134,"threshold_uncertainty_score":0.101495564},"labels":[],"label_agreement":null},{"id":"W4404421282","doi":"10.1016/j.jbo.2024.100649","title":"A patch-based deep learning MRI segmentation model for improving efficiency and clinical examination of the spinal tumor","year":2024,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"Xiangya Hospital, Central South University; Central South University","keywords":"Medicine; Segmentation; Deep learning; Magnetic resonance imaging; Radiology; Medical physics; Artificial intelligence","score_opus":0.017850508689985858,"score_gpt":0.32207407549422123,"score_spread":0.3042235668042354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404421282","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07190338,0.00069080904,0.9241135,0.0002841766,0.000060007973,0.00006635787,0.00015972547,0.0015772383,0.0011448404],"genre_scores_gemma":[0.78680587,0.0005822107,0.20598626,0.00030132278,0.00007764934,0.00012712134,0.00060590735,0.00021424507,0.0052993936],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998136,0.000021562146,0.000011220741,0.00007735336,0.000046325502,0.000029893452],"domain_scores_gemma":[0.9997609,0.00006744453,0.000036325837,0.000026217422,0.000092055554,0.000017007369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043936353,0.00059389154,0.0007161611,0.00069136726,0.00020976886,0.00050029845,0.00093527354,0.0009668031,0.0012572274],"category_scores_gemma":[0.0010006283,0.00034408245,0.0007191741,0.0003979755,0.00031417966,0.00062793866,0.00052789866,0.0006074147,0.0004600699],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033453255,0.000146824,0.004228269,0.00012190782,0.000113816364,0.0001897161,0.00006955172,0.6406637,0.03014533,0.0021874772,0.0031597768,0.31863907],"study_design_scores_gemma":[0.0000031076481,0.000019140305,0.00022867318,0.0000024255069,0.000010167725,0.000030671155,0.0000020283967,0.99726117,0.0019914773,0.00027115268,0.00017702844,0.0000028953982],"about_ca_topic_score_codex":0.006882438,"about_ca_topic_score_gemma":0.006472146,"teacher_disagreement_score":0.006882438,"about_ca_system_score_codex":0.0007823752,"about_ca_system_score_gemma":0.0008845756,"threshold_uncertainty_score":0.01368475},"labels":[],"label_agreement":null},{"id":"W4411219742","doi":"10.1016/j.jbo.2025.100694","title":"Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG","year":2025,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Aromatase inhibitor; Aromatase; Breast cancer; Gynecology; Estrogen; Oncology; Cancer; Internal medicine","score_opus":0.015430125091982985,"score_gpt":0.3312047782452184,"score_spread":0.3157746531532354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411219742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010065549,0.9522495,0.0012720424,0.037754532,0.0045438437,0.00052265596,0.0011984623,0.000036849564,0.0014154841],"genre_scores_gemma":[0.015117421,0.9390686,0.012332279,0.024424028,0.0045377784,0.0015263015,0.0018215232,0.000037861297,0.0011342261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9707334,0.008674983,0.01113969,0.0010165694,0.007789167,0.00064622454],"domain_scores_gemma":[0.9478164,0.020458173,0.01695197,0.00095141836,0.012799705,0.0010223752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03486486,0.0019081053,0.0054853293,0.00591506,0.0009984561,0.0039011196,0.0032090857,0.0053247497,0.002181808],"category_scores_gemma":[0.07483558,0.0011435607,0.0063000466,0.004766698,0.0013028124,0.0026280968,0.0033252698,0.004594348,0.0007955104],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010324059,0.00013606147,0.004796376,0.32966214,0.010138107,0.00035514496,0.00067785784,0.0009046787,0.0013720954,0.0032228967,0.1580018,0.48970047],"study_design_scores_gemma":[0.0012658725,0.00051857304,0.010880896,0.5156839,0.030678192,0.0011623247,0.00039173992,0.0005902099,0.0009689781,0.004574002,0.43307385,0.00021152552],"about_ca_topic_score_codex":0.009030729,"about_ca_topic_score_gemma":0.0168265,"teacher_disagreement_score":0.03486486,"about_ca_system_score_codex":0.0035205283,"about_ca_system_score_gemma":0.018198824,"threshold_uncertainty_score":0.18438518},"labels":[],"label_agreement":null},{"id":"W4416713338","doi":"10.1016/j.jbo.2025.100732","title":"Rotationplasty performed in adults versus minors: a comparative study of long-term quality of life, functional and biomechanical outcomes","year":2025,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Scoliosis diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"JKF Kinderfonds","keywords":"Gait; Quality (philosophy); Quality of life (healthcare); Biomechanics; MEDLINE; Gait analysis","score_opus":0.11300880445292927,"score_gpt":0.43508066212931623,"score_spread":0.32207185767638696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416713338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631256,0.003218681,0.000054949276,0.000015680374,0.000012931456,0.000030813702,0.00013460476,0.0000012700843,0.00021851656],"genre_scores_gemma":[0.99811447,0.0013688707,0.00008595262,0.00003512275,0.000033361488,0.00003625204,0.00025629697,0.0000010756173,0.000068645655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914956,0.0002592867,0.0001984124,0.0001383118,0.00016967018,0.00008463052],"domain_scores_gemma":[0.9979165,0.0005582058,0.0010467608,0.00007601556,0.00014362556,0.000258984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013012649,0.00031175508,0.0009921489,0.0011173546,0.0002461305,0.0004087246,0.00018599206,0.00038523163,0.0013593308],"category_scores_gemma":[0.0022291318,0.00020460208,0.0010845115,0.0011720647,0.00036208282,0.00048388666,0.0004038675,0.00026551544,0.00018134927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011361233,0.0009365261,0.9555976,0.00092070363,0.0021082736,0.0003399848,0.00044630616,0.00006808173,0.0008475458,0.00005640762,0.00022602052,0.027091319],"study_design_scores_gemma":[0.0007530238,0.017965512,0.9768818,0.00016383326,0.0009295012,0.0015188392,0.00087941234,0.000088804365,0.0001818101,0.000030656473,0.00058800227,0.00001886408],"about_ca_topic_score_codex":0.0006653934,"about_ca_topic_score_gemma":0.0011808651,"teacher_disagreement_score":0.0013593308,"about_ca_system_score_codex":0.00034904122,"about_ca_system_score_gemma":0.00032334338,"threshold_uncertainty_score":0.0068817735},"labels":[],"label_agreement":null},{"id":"W592913892","doi":"10.1016/j.jbo.2015.04.001","title":"Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study","year":2015,"lang":"en","type":"article","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ontario Clinical Oncology Group; McMaster University; Ottawa Hospital; University of Ottawa","funders":"Government of Ontario; Ontario Institute for Cancer Research","keywords":"Medicine; Vandetanib; Fulvestrant; Oncology; Internal medicine; Placebo; Breast cancer; Metastatic breast cancer; Clinical trial; Cancer; Pathology; Tamoxifen","score_opus":0.03941192893059437,"score_gpt":0.37982618001559265,"score_spread":0.3404142510849983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W592913892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997544,0.0016788695,0.00007031601,0.000039211285,0.000006196404,0.00017398417,0.00029736798,0.0000027264866,0.00018728185],"genre_scores_gemma":[0.9978981,0.00060722575,0.0002039921,0.00006776881,0.000023904779,0.00023565625,0.0006841134,0.0000017997346,0.00027739405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958926,0.00013150106,0.00004505836,0.00007859434,0.000069573645,0.00008606451],"domain_scores_gemma":[0.9993476,0.00014312465,0.00029731527,0.000056952504,0.00005988949,0.0000950633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013007561,0.0005180676,0.0013019542,0.00042194885,0.00024010794,0.00054844574,0.0003294384,0.0004843742,0.0012452055],"category_scores_gemma":[0.0013206103,0.00035406437,0.0009168853,0.00051916507,0.0003364907,0.0002933703,0.00035819787,0.00058504875,0.0001507579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37018192,0.0032093418,0.5599149,0.0011456227,0.005428653,0.00017950042,0.00035089804,0.0009391605,0.0118245315,0.00013575684,0.0008376932,0.04585211],"study_design_scores_gemma":[0.033622574,0.0333573,0.92574185,0.00008088366,0.0035433196,0.00021734826,0.000111014335,0.0007637001,0.00083867414,0.000062014944,0.0016315818,0.000029754014],"about_ca_topic_score_codex":0.0024272662,"about_ca_topic_score_gemma":0.003392886,"teacher_disagreement_score":0.0024272662,"about_ca_system_score_codex":0.0006708062,"about_ca_system_score_gemma":0.00059961644,"threshold_uncertainty_score":0.0068790913},"labels":[],"label_agreement":null},{"id":"W788640686","doi":"10.1016/j.jbo.2015.06.001","title":"Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting","year":2015,"lang":"en","type":"review","venue":"Journal of bone oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"National Institutes of Health","keywords":"Medicine; Bisphosphonate; Breast cancer; Adjuvant; Stage (stratigraphy); Oncology; Internal medicine; Cancer; Randomized controlled trial; Gynecology; Osteoporosis","score_opus":0.031430261538737056,"score_gpt":0.34375880872806147,"score_spread":0.3123285471893244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W788640686","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006414393,0.9973084,0.000016200163,0.0023305377,0.00014320263,0.0000024996332,0.0000098930495,7.934334e-7,0.00012439927],"genre_scores_gemma":[0.0016309435,0.99638474,0.00012148356,0.0015435744,0.0002103007,0.000006299614,0.00001554485,9.0447554e-7,0.00008626551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826425,0.00073688745,0.00036310308,0.00014785191,0.00041844638,0.0000695306],"domain_scores_gemma":[0.9956174,0.0026508793,0.0006485006,0.00008068862,0.0008817576,0.000120856326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045910715,0.00040106176,0.0026192302,0.0012680214,0.00026017427,0.0016557681,0.0011612694,0.0019051271,0.0020026679],"category_scores_gemma":[0.011653335,0.00038283368,0.0014488023,0.0020480314,0.00069894106,0.0019575572,0.00048216627,0.0029505542,0.00038483102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051186036,0.00003736736,0.00039242566,0.09469474,0.0012103395,0.00006810156,0.0001759552,0.00021809756,0.0003924528,0.005431998,0.035619225,0.86124754],"study_design_scores_gemma":[0.00047340294,0.0003257516,0.0039186957,0.18380682,0.0046375003,0.0004959302,0.0004816641,0.0001743794,0.00031842384,0.0074497196,0.79786336,0.000054316122],"about_ca_topic_score_codex":0.009390611,"about_ca_topic_score_gemma":0.019973723,"teacher_disagreement_score":0.009390611,"about_ca_system_score_codex":0.001894162,"about_ca_system_score_gemma":0.005019804,"threshold_uncertainty_score":0.02428025},"labels":[],"label_agreement":null}]}